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DETECTION OF YvfI-SinR CO-REGULATED GENES AND 
THE EFFECT OF Deg-U TRANSCRIPTIONAL FACTOR ON THE 
EXPRESSION OF YvfI GENE in Bacillus subtilis 
SUMMARY 
Bacillus subtilis is a rod-shaped gram positive, nonpathogenic bacterium. It has 
various skills that enable the adaptation of bacterium  a high adaptability to harsh 
enviromental conditions. B. subtilis can synthesize antibiotics (bacilysin, surfactin 
etc.), release degradative enzymes (e.g. protease), undergo chemotaxis, sporulate and 
synthesize biofilm. Hence, it is able to sense unsuitable conditions and alternate its 
response. Its genome is 4,2 Mbp and completely sequenced and encode about 4,100 
different genes.  
GntR family proteins are classified as a transcriptional repressor proteins which are 
responsible for the regulation of more than 2000 altered proteins. Moreover, 
numerous regulons which have different functions are under the control of these 
proteins which behave as regulators.  
According to the recent studies, YvfI is a novel gene belonging to B. subtilis which 
was reported to have a significant role in bacilysin biosynthesis. It contains a FadR 
C-terminal ligand binding (FCD) domain  which is common  in GntR family 
proteins. Additionaly, YvfI was proposed to regulate yvfV-yvfW-yvbY (lutABC) 
operon that is responsible for lactate utilization in Bacillus subtilis. 
SinR protein is known as a transition state regulator and it regulates the transcription 
of the roc gene negatively. Rok protein is responsible for negative regulation of 
ComK that encodes the competence transcription factor. Furthermore, when rok is 
inactivated, it bypasses the positive obligation of SinR for ComK expression. 
Moreover, SinR can inhibit potentially unsuitable functions during exponential 
growth if there is no need for these functions. Addition to YvfI and SinR proteins, 
DegU protein has also a regulatory effect on development of genetic competence. 
DegU and histidine protein kinase DegS play an active role in the synthesis of 
degradative enzymes at the onset of competence development. 
 In this present study, 38 YvfI-target genes, which have been identified previously by 
employing a genome wide comparative transcriptome analysis and Electromobility 
Shift Assays (EMSA), were screened to analyze the overlap between YvfI and SinR 
DNA targets. For this, Electromobility Shift Assays were performed with increasing 
concentrations of purified SinR or YvfI alone and in the presence of both regulators 
in which the fixed amount of one of them was mixed with the increasing 
concentrations of the others. Subsequently, when these genes were clustered  based 
on  their known or presumed functions, YvfI and SinR appears to participate to the 
regulation of genes involved in various metabolic and physiological processes 
associated with the postexponential phase in B. subtilis including degradative 
enzyme production, antibiotic production and resistance, carbohydrate utilization and 
xx 
 
transport, nitrogen metabolism, phosphate uptake, fatty acid and phospholipid  
biosynthesis, protein synthesis and translocation, cell-wall metabolism, energy 
production, transfer of mobile genetic element, induction of phage-related genes, 
sporulation, delay of sporulation and cannibalism and biofilm formation. This study 
revealed a significant overlap between the YvfI and SinR targets, proposing a 
possible co-regulatory role of YvfI and SinR proteins by directly binding on the 
promoter regions of previously identified YvfI affected genes in order to provide the 
adaptation of B. subtilis cells to changing conditions.  
In this study the direct regulatory effect of DegU protein on YvfI gene was also 
studied by employing  Electromobility Shift Assay (EMSA) analysis. 
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YvfI-SinR PROTEİNLERİ TARAFINDAN BİRLİKTE DÜZENLEDİKLERİ 
GENLERİN BELİRLENMESİ ve Deg-U TRANSKRİPSİYON FAKTÖRÜNÜN 
Bacillus subtilis’ DEKİ YvfI GENİNİN EKSPRESYONUNA ETKİSİ 
ÖZET 
Gram pozitif bakteriler arasında yer alan Bacillus subtilis, çubuksu yapısı,patojen 
özellikte olmaması ve sporlanabilmesi gibi öne çıkan özellikleriyle tanımlanan bir 
bakteri türüdür. Bu bakteriye günlük yaşantımız içinde toprakta sıklıkla rastlamak 
mümkündür.  
B.subtilis rakipleriyle mücadele edebilme konusunda birçok avantaja sahiptir. On 
ikiden fazla çeşitlilikte antibiyotik üretebilmesi en çarpıcı özellikleri arasındadır. 
Bunun yanı sıra sahip olduğu kemotaksis kabiliyetinin sonucu olarak katı yüzeylerde 
kayarak yer değiştirebilmesi, olumsuz şartlarda sporlanabilmesi ve kompetans 
geliştirebilmesi B. subtilis türünü rakipleriyle mücedelesinde öne çıkaran avantajlar 
arasındadır.  
Bacillus subtilis,  genomunun tamamı dizilenmiş bir organizmadır. Ayrıca patojen 
özellikte olmaması sebebiyle kolay kontrol edilebilir bir türdür. Bölünme ve büyüme 
hızı, kolay transforme olabilme yeteneği, yüksek adaptasyon kabiliyeti, çeşitli 
antibiyotikleri, enzimleri ve biyokimyasalları üretebilmesi sayesinde bilimsel 
araştırmalarda sıklıkla yer alan bir model organizmadır. 4,2 Mbp uzunluğundaki 
genomunun tamamının dizilenmesi  sonucunda, organizma genomunun yaklaşık 
olarak 4,100 genin kodlanmasından sorumlu olduğu görülmüştür. Bu genlerin 
haritalanması ile türe özgü fonksiyonların gerçekleştirilmesinden sorumlu olan 
kısmın, toplam bakteri genomunun üçte birlik bir kısmı olduğu anlaşılmıştır. 
Haritadaki geri kalan üçte ikilik kısmın sahip olduğu fonksiyonları aydınlatma 
amacıyla yapılan çalışmalar hala sürmektedir.    
Bacillus subtilis bulunduğu ortamdan gelen sinyallere ve ortamdaki bileşenlerin 
sağladığı büyüme şartlarına paralel olarak fizyolojik değişimler sergileyebilen bir 
bakteridir. Bu bakterinin sahip olduğu gelişmiş adaptasyon kabiliyeti sayesinde 
geçirdiği değişimler, morfolojik ve fenotipik açıdan net yansımalar gösterir. B. 
subtilis’i fizyolojik açıdan değişime teşvik eden sebepler arasında, ortamdaki besin 
kaynaklarının kullanılabilirliği ve diğer organizmalarla besin kaynaklarına karşı olan 
rekabet, ortamın sıcaklığı, pH değeri ve oksijen miktarının bakterilerin optimum 
değerlerinin dışında olması ve bakterilerin büyüme hızındaki değişiklikler sayılabilir. 
Örnek vermek gerekirse, logaritmik büyüme evresinin sonlarına gelmiş ve besin 
kaynaklarında azalmayla karşılaşmış bir bakterinin kemotaksis metabolizması 
uyarılır ve canlılığını sürdürebilmek için çeşitli stratejiler geliştirmeye zorlanır. Bu 
kıtlık durumu devam ederse, hareket ederek besin bulmayı hedefleyen bakteride, bu 
sefer de ortamdaki diğer mikroorganizmaları bu yarıştan uzaklaştırmak için 
antimetabolik, antifungal ve antimikrobiyal özellikteki antibiyotiklerin üretimi 
tetiklenir. Bu besin kıtlığıyla baş edebilme çözümlerine ek olarak, aynı şekilde 
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ortamdaki besin seviyesinde azalma söz konusu olduğunda, farklı besinleri kaynak 
olarak kullanabilmek için proteaz üretimine, kompetans geliştirerek yabancı 
DNA’nın hücre içine alımına ya da sporlanmaya yönelebilen B. subtilis, olumsuz  
şartlarda geliştirdiği çeşitli mekanizmalarla hayatta kalmayı başarabilen bir 
mikroorganizmadır.  
B. subtilis’ in genomunun tamamının dizilenmesiyle ortaya çıkan diğer özellikler de, 
üretebildiği ikincil metabolitler arasında antibiyotiklerin ve sanayileşme açısından 
önemli olan enzimlerin de olmasıdır. Bu özelliklere ek olarak, bu mikroorganizmanın 
karbon kaynaklarının kullanımındaki çeşitlilik de göze çarpmaktadır. Hatta, 10’a 
yakın profaj ve benzeri yapının B. subtilis’in genomu tarafından kodlanabildiği tespit 
edilmiştir. Bu sayede de bakteriyel evrim sürecinde bakteriyofaj enfeksiyonlarının 
gerçekleşebileceği gen transferinde etkili olabilmeleri söz konusu olabilir. Ayrica, 
mikroorganizmanın sahip olduğu 77 aday ATP-bağlayıcı taşıyıcı proteinden oluşan 
en büyük gen ailesi ve buna  benzer diğer büyük gen ailelerinin varlığının gen 
duplikasyonları sonucu oluştuğu düşünülmektedir.  
Prokaryotlarda sinyal iletim mekanizması, sinyal reseptörleri ve gelen bu sinyallere 
cevap verebilecek özellikteki kısımlardan oluşur. Sarmal-dönüş-sarmal (helix-turn-
helix) bölgesi ise fonksiyonel çıktı bölgesinin önemli bir kısmını karşılamaktadır. 
DNA’ya karşı afiniteye sahip ve bağlanabilme özelliğindeki kısımların 
dizilimlerindeki benzerliklerin oranı fonksiyonel sinyal algılayabilme ve bu 
sinyallere karşılık verebilme yetisindeki bölgelere sahip olan proteinlerdeki tek 
bileşenli sistemlerin ve HTH transkripsiyonel düzenleyicilerinin gruplandırılmasında 
belirleyici bir kriterdir. Bu transkripsiyonel düzenleyici proteinlerin farklı türleri 
mevcuttur. Bu türler arasında bulunan genel olarak kanatlı sarmal-dönüş-sarmal 
motifiyle tanımlanan GntR gen ailesi de vardır. Bu gen seti birbirinden farklı aksiyon 
bölgelerini ve farklı organizmalarda da işlevsellik gösterebilen 2000’e yakın farklı 
proteini barındırmaktadır. GntR ailesine ait 4 önemli altgruptan ilki ve en kalabalık 
olanı FadR alt grubudur. Bu alt grup benzer proteinlerin sahip olduğu fonksiyonlara 
ek olarak sahip olduğu geniş çeşitlilikle diğerlerinden ayrılmaktadır. Bu bilgilerin 
yanında aminoasit metabolizmasının düzenlenmesinin ve kontrolünün, aspartat, 
glukonat, laktat, galaktonat, pirüvat ve malonat gibi metabolik yol izlerinin FadR alt 
grubuna ait proteinlerle alakalı olduğu belirlenmiştir. Bu genlere ek olarak, yakın 
tarihte çalışılmış eski adı YvfI olan ve artık son çalışmalarda LutR olarak 
adlandırılan B. subtilis geninin, GntR ailesinin FadR altgrubunun C-ucu ligand 
bağlayan bölgesini içerdiği kanıtlanmıştır. Dahası bu gen B. subtilis’in ürettiği 
önemli bir antibiyotik olan basilisin üretiminde önemli bir rol oynamaktadır. Bacillus 
subtilis’e ait PY79 suşunun basilisin antibiyotiğinin üretim metabolizmasında da  
etkilidir. Bu metabolizmada etkili olan genlerin belirlenmesi amacıyla Tn10 
mutagenesis çalışmaları gerçekleştirilmiş ve GntR ailesine ait YvfI transkripsiyonel 
regülatorünün basilisin üretiminde rol aldığı kanıtlanmıştır. Bu bulguya paralel 
olarak da YvfI geninin regülasyonundan sorumlu herhangi bir genin, dolaylı yoldan 
da olsa basilisin üretiminde regülatör rol üstlendiği yorumu yapılmıştır. Geniş bir 
spektrumda bakterilere ve bazı mantar türlerine karşı etki gösterebilme yeteneğine 
sahip dipeptit basilisin antibiyotiği C ucunda L-antikapsin ve N ucunda L-alanin’den 
oluşur. Basilisin antibiyotiği antimikrobiyal özelliğini doğal olarak protein özellikleri 
taşımayan L-antikapsin aminoasidinden alır. Yakın tarihli çalışmalarla, basilisin 
biyosentez mekanizması aydınlatılmış ve ywfBCDEFG (yeni ismisyle bacABCDE) 
polisistronik operonu ve ywfH monosistronik geniyle olan ilişkisi üzerinde 
durulmuştur. Yapılan çalışmalarla elde edilen sonuçlara bakıldığında, bacABCDE 
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operonundaki bacA, bacB ve bacC genlerinin etki mekanizmasının antikapsin 
üretimi olduğu, bacD ve bacE genlerinin ise aminoasit ligasyonu ve basilisin 
antibiyotiğinin olumsuz etkilerine karşı dirençli olma mekanizmaları üzerinde etkili 
olduğu görülmüştür. Bunların dışında, 44 aminoasit daha içeren YvfI proteininin 
genişletilmiş formunun birebir olmasada GntR gen ailesine benzer proteinlerin 
içerdiği kanatlı sarmal-dönüş-sarmal bölgesiyle büyük oranda benzerlik gösterdiği 
keşfedilmiştir. Bütün bu bulguların ötesinde, henüz tamamlanmış çalışmalarla 
YvfI’ın baskın bir şekilde yvfV-yvfW-yvbY genlerinden oluşan lutABC operonunun 
kontrolünü üstlendiği görülmüştür. 
Bacillus subtilis’deki regülasyon mekanizmaları arasında önemli bir rol üstlenen 
birimlerden biri de Spo0A proteinidir. Bir global regülator olan Spo0A sporlanma 
sürecinin başlatılmasında üstlendiği kritik rolün yanısıra basilisin biyosentezi 
üzerinde de pozitif regülasyon etkisine sahiptir. Aynı zamanda AbrB ve CodY global 
geçiş fazı regülatorleri tarafından da logaritmik faz sürecinde baskılanabilmektedir. 
SinR proteini B. subtilis’in geçiş fazıboyunca etki gösteren önemli regülatörlerden 
biridir. Eksponansiyel büyüme esnasında ihtiyaç duyulmayan faaliyetlerin 
engellenmesinde rol alır. Ayrıca SinR’ın aşırı üretimi, negatif etki söz konusu 
olmaya başladığında sporulasyon mekanizmasını inhibe eder. Bunların dışında 
proteaz aktivitesi üzerinde negatif regülasyon etkisine sahiptir. SinR proteinin bir 
diğer özelliği de ComK proteininin negatif düzenlenmesinden sorumlu Rok proteinin 
transkripsiyonunu negatif olarak etkileyebilmesidir. Rok proteininin inaktif olması 
halinde SinR’ın ComK ekspresyonu esnasındaki rolü pozitif olarak düzenlenmiş 
olur.      
DegU proteini ise B. subtilis’deki bir diğer önemli regülasyon elemanıdır. 
Mikroorganizmanın sahip olduğu, geçiş fazı süreci veya besin kıtlığı gibi ekstrem 
durumlarla mücadele edebilmesini sağlayan; hücre dışında parçalayıcı etki gösteren 
enzim üretimi ve salınımı, kompetans oluşumu, biyofilm oluşumu gibi 
mekanizmaların indüklenmesini sağlayan regülatorlerden biri olan DegU proteini 
degU genitarafından kodlanır. Yapılan bu çalışmada, daha önceden grubumuzda 
uygulanan genom düzeyinde karşılaştırılmalı transkriptom analizi ve 
“Electromobility Shift Assay (EMSA) methodu” ile belirlenen YvfI transkripsiyonel 
faktörünün direkt kontrolü altında bulunan38 genin, regülatör  bölgesi çoğaltılarak,  
YvfI and SinR proteinleri ile birlikte EMSA deneyleri yapılmış ve yorumlanmıştır. 
Bu genler ilgili oldukları alanlara göre, nitrojen metabolizması, karbonhidrat 
mekanizması, antibiyotik üretimi ve direnci, B. subtilis deki mobil genetik 
elementlerin düzenlenmesi, sporlanma, sporlanmanın ertelenmesi ve rekabet sonucu 
oluşan yamyamlık mekanizmaları, biofilm oluşumu  mekanizması, fajlarla alakalı 
genlerin aktivasyonu ve potasyum alımına göre sınıflandırılmıştır. Sonuç olarak, 
YvfI regülator proteinin direk etkisi altında bulunan  38 gen bölgesinin aynı zamanda  
SinR regülator proteininin direk etkisi altında bulunduğu gösterilmiştir. Tüm bu 
verilere,YvfI proteininin  SinR  regülatör proteini ile birlikte hareket ederek, Bacillus 
subtilis türünün değişen çevre koşullarına uyum sağlamasını sağlayan mekanizmaları 
birlikte yönettiklerine işaret etmektedir.  
 Bu çalışmalardan ayrı olarak önemli global regülatörlerden biri olan DegU proteinin 
YvfI geni üzerindeki direk etkisi yine aynı şekilde EMSA deneyleriyle tespit 
edilmiştir. 
 
 
xxiv 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
xxv 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xxvi 
 
 
 
 
 
 
 
 
 
 
1 
1. INTRODUCTION 
1.1. Purpose of Thesis 
This present study aimed to analyze the overlap between YvfI and SinR DNA 
targets. For this purpose, Electromobility Shift Assay (EMSA) were performed to 
analyze whether SinR would interact with the regulatory regions of all or only some 
YvfI-target genes and/or they would affect each other’s binding. Furthermore, this 
thesis also aimed to clarify the role of DegU global regulatory protein on the 
expression of the yvfI gene.  
1.2 Bacillus subtilis 
Bacillus subtilis is a gram positive microorganism which has high adaptation 
capability. Thus, it can cope with unsuitable enviromental conditions easily owing to 
its properties. This bacterium is omnipresent such that it can be found in soil, plant 
root, gastrointestinal system of marine or continental animals (Sonenshein et al., 
1993).Distinguishing properties which belong to Bacillus subtilis include 
sporulation, chemoorganotrophy, secretion of a variety of secondary metabolites, 
modification of physiology for adaptation against unsuitable enviromental 
conditions. Moreover, B. subtilis ability of encoding a putative respiratory nitrate 
reductase was discovered previously. Hence, when there is depleted oxygen source in 
medium, B. subtilis can survive and grow under anaerobic conditions thorough using 
nitrate as electron acceptor (Glaser et al., 1995; Ramos et al., 1995; Earl et al., 
2008). Furthermore, Bacillus subtilis, as being a chemoorganotroph, can oxidize 
many organic compounds and therefore it has the ability of growing in simple salt 
medium (Trun and Trempy, 2004; Harwood et al. 1990). Nevertheless, Bacillus 
subtilis can adapt easily to nutritional limitation or other stress elements. One of the 
outcomes of these stress-coping adaptations is endospore development (Earl et al., 
2008; Harwood et al., 1996; Glaser et al., 1995; Ramos et al., 1995; Stein et al., 
2005). Also, chemotaxis, motility, antibiotic and extracellular macromolecules-
degrading enzyme production are other reactions that are displayed by B. subtilis 
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against unsuitable conditions (Msadek, 1999; Hardman et al., 1998). Furthermore, B. 
subtilis can produce more than two dozen antibiotics(antibacterial, antimetabolic, 
antifungal) ribosomaly or non-ribosomaly in order to eliminate other competitor 
microorganisms. This bacterium has also the ability to secrete insecticides (e.g. 8-
endotoxins) and hydrolytic enzymes (e.g. amylases, alkaline proteases) to benefit 
from other alternative nutrition sources and biochemicals (e.g. nucleosides for 
conversion to flavour enhancers) (Kobayashi and Ogasawara, 2002; Nicholson et al., 
1990). Moreover, uptake of exogenous DNA and sporulation are also performed by 
Bacillus subtilis (Sonenshein et al., 1993; Hamoen et al., 2003).  
1.2.1 Quorum Sensing Mechanism in Bacillus subtilis 
Several cells control their gene expression by cell-cell signaling systems. Quorum 
sensing mechanism includes regulatory responses that are given according to cell 
density (Fuqua et al. 1994). If cell density reaches to a threshold level, bacteria can 
sense it and reacts to this situation at the gene expression level (Grossman,1996). 
Specially, small peptides, known as pheromones, are the signal molecules which are 
sensed by Gram-positive bacteria (Lazazzera ,2000). There are a direct interaction 
between these pheromones and receptors which are on the surface of cell. An 
oligopeptide permease provide to transport of  peptide pheromones into the cell. 
Then, interaction between the pheromones and intracellular receptors causes a 
reaction which is directly related to gene expression level (Lazazzera and 
Grossman,1998). In Bacillus subtilis, ComP–ComA (components of signal 
transduction system) and ComX–CSF (pheromones of competence and sporulation 
factor) play an active role at the regulation of quorum sensing responses (Ozcengiz 
et.al.,2002). This regulatory system is under the control of ComX pheromone and 
CSF competence and sporulation factor. Furthermore, this dual peptide factors are 
responsible for the stimulation of srfA operon trasncription (Grossman,1999). 
 
Figure 1.1: Genetic map of QS genes in B. subtilis (Tortosa and Dubnau,1999) 
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DegS and DegU are parts of a two-component signal transduction regulatory system 
that are involved in the production of many degradative enzymes such as 
extracellular proteases, α-amylase, proteases (Tanaka et al., 1991). DegS is a 
histidine protein kinase and phosphorylated form of DegU contributes to degredative 
enzyme synthesis, whereas nonphoshorylated form of DegU is required for 
expression of genetic competence (Hamoen et al., 2000; Hameon et al., 2003; 
Susanna et al., 2006). Furthermore, exoprotease enzyme secretion, motility and 
competence development are among the processes which are controlled by DegS-
DegU proteins in Bacillus subtilis. Moreover, a mutation which occurs on the degU 
may lead to reduced expression of srfA gene which is crucial for competence 
regulation (Dubnau, 1991; Dahl et al., 1992). 
1.3. Bacillus subtilis Antibiotics 
Members of Bacillus genus are known to produce many antibiotics whichdisplay 
numerous antimicrobial actions. For instance, while bacitracin, laterosporin, 
tyrocidin, pumulin and gramicidin show their effects on Gram-positive bacteria,  
polymyxin and colistin show their effect on Gram-negative bacteria. In addition to 
this, difficidin antibiotic which has a wide-range spectrum can be secreted 
assecondary metabolite (Stein et al., 2005; Trun and Trempy, 2004). Moreover, 
Bacillus subtilis strains have ability of synthesizing a variety of antifungal agents like 
small antibiotic peptides. Molecular weight of these antifungal agents is about 2000 
Da and these agents include bacilysin, surfactin, mycobacillin, bacillomycin, iturin, 
mycosubtilin, fengymycin and B291. (Majumdar and Bose, 1960; Sengupta et 
al., 1971; Tsuge et al., 2001; Stein, 2005; Peypoux et al., 1999; Carrillo et al., 2003; 
Peypoux et al., 1980, Peypoux et al., 1986; Li et al., 2009). In addition to anti-
microbial functions, B. subtilis antibiotics also play a role at the determination of 
morphological and physiological state of the organism Meanwhile, peptide 
antibiotics are secreted either ribosomaly or non-ribosomaly. They are synthesized 
ribosomaly via post-translational alteration and proteolytic  mechanism andnon-
ribosomaly via megaenzymes that are non-ribosomal peptide synthetases (NRPSs) 
(Katz and Demain, 1977; Stein, 2005; Li et al., 2009; Moszer, 1998). 
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1.3.1 Bacilysin 
Several strains of Bacillus subtilis can synthesize 125 kDa bacilysin antibiotic and 
secreted extracellularly. Structure of bacilysin antibiotic is formed by two amino acid 
(Figure 1.2). One of these, is L-alanine aminoacid that is at N-terminus and the other 
is L-anticapsin aminoacid that is at C-terminus (Walker and Abraham, 1970). 
Bacilysin antibiotic active against various bacteria and also  certain fungi, 
specifically Candida albicans (Steinborn et al., 2005).  
 
 
 
 
 
 
 
Figure 1.2: Chemical structures of bacilysin (Walker & Abraham, 1970) 
 
Figure 1.3: Bacilysin, surfactin, subtilin and subtilosin biosynthesis pathway in   
Bacillus subtilis (Stein, 2005). 
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In Bacillus subtilis 168, bacABCDEywfG operon (formerly named as ywfBCDEFG) 
and ywfH monocistronic gene are responsible for  the biosynthesis of bacilysin 
(Inaoka et al., 2003). bacABC (formerly ywfBCD) is responsible for anticapsin 
biosynthesis, bacD (formerly ywfE) takes part in ligation of anticapsin to alanine, 
bacE (formerly ywfF) in self-defence of bacilysin. Also, ywfB and ywfG genes are 
necessary for prephenate dehydratase and aminotransferase synthesis. They are 
components of anticapsin manufacturing process from aromatic amino acid 
prephenate (Hilton et al., 1988; Inaoka et al., 2003; Steinborn et al., 2005). 
Furthermore, ywfH plays a role at the ligation of alanine-anticapsin according to the 
current knowledge (Inaoka et al., 2003) (Figure 1.4)  
 
Figure 1.4: Total  appearance  of  the   bacilysin   gene   cluster   ywfABCDEFG  and  
additionally ywfH gene of Bacillus subtilis 168 (Inoaka et al., 2003) 
According to the findings of recent studies, biosynthesis of bacilysin is controlled 
synergistically by guanosine 5‟-diphosphate 3‟-diphosphate (ppGpp) and guanosine 
triphosphate (GTP) affecting CodY-mediated respression of bacABCDE operon 
(Inaoka et al., 2003). There are two small-molecule which are related with the 
regulatory role of the CodY protein. One of these small-molecules is GTP. It behave 
as a repressor and there is an affinity between the CodY protein and GTP molecule. 
GTP has activation ability on the CodY. Second small molecule constitutes of 
branched-chain amino acids (BCAAs) isoleucine and valine. This molecule interacts 
with the CodY and improve its binding capacity on the target sites (Joseph et al., 
2005). Furhermore, bacilysin production is known to be regulated on different levels 
negatively by transcriptional regulators CodY and AbrB (Inaoka et al., 2003; Yazgan 
et al., 2003). Moreover, Hpr work together with AbrB and CodY proteins as 
regulator during transition phase and they show negatively regulation effect on the 
bacilysin production in Bacillus subtilis (Inaoka et al., 2009).   
Additionally, a new gene called YvfI (recently named as lutR) was stated by Koroglu 
and her colleagues (2008) to be related with bacilysin production. 
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1.3.1.1 YvfI, a GntR-Type Regulatory Protein, Involved in Bacilysin Production 
In addition to global regulatory genes that were reported to be involved in bacilysin 
biosynthesis in Bacillus subtilis, a novel gene, YvfI was further stated to be crucial 
for the biosynthetic pathway of this antibiotic (Koroglu et al., 2008). This study has 
pointed three mutants that are unable to produce bacilysin using transposon 
mutagenesis studies.These independent mutant isolates were shown to carry the same 
insertional mutation on the same locus using southern blot analysis. Furthermore, as 
a result of sequencing analysis, Tn10 inserted region was identified to be YvfI gene 
(Figure 1.5). 
Figure 1.5: Genomic structure of the YvfI gene and peripheral chromosomal sites 
(Kunst et al., 1997). Besides, given is the 427 or 460 nucleotide long 
transposon insertion in the YvfI gene (Koroglu et al., 2008). 
Hence, functionally, Tn10 insertion on YvfI gene has proven that YvfI was important 
for dipeptide antibiotic bacilysin biosynthesis in Bacillus subtilis (Köroğlu et al., 
2008).  
A conserved Domain Database (CDD) (Marchler-Bauer et al. 2005) for YvfI protein 
pointed out that YvfI protein displays FadR C-terminal ligand binding (FCD) domain  
at its C-terminal and it should be noted that this domain is known to be very common 
among GNTR family of proteins. 44 amino acid extended YvfI protein (Kunst et al., 
1997) was also determined which exhibited a partial but considerable match with the 
GntR wHTH domain. Furthermore, studies on YvfI sequence revealed high 
homology with its ortholog protein from different species including FadR (Marchler-
Bauer et al., 2005). FadR-like proteins are associated not only to the regulation of 
amino acids  metabolism but also to various metabolic pathways such as aspartate 
(AnsR), pyruvate (PdhR), glycolate (GlcC), galactonate (DgoR), lactate (LldR), 
malonate  (MatR), or gluconate (GntR) (Rigali et al., 2002).   
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Additionally, YvfI gene takes a part as the regulator of yvfV-yvfW-yvbY (lutABC) 
operon responsible for lactate utilization (Chai et al., 2009).  Moreover, lutABC 
operon was also proposed to be controlled by SinR protein by Chai and his group 
(2009). This study further pointed out that YvfI and SinR proteins behave as co-
regulators on the lutABC operon (Figure 1.6). It should be noted that SinR can 
supress 18 genes which are related to yqxM-sipW-tasA and epsA-to-O operons. These 
two operons are known as regulators of extracellular matrix construction. Also, SinI 
protein behaves as an antirepressor to SinR (Branda et al., 2005; O’Toole and 
Kaplan, 2000; Stoodley et al., 2002; Sutherland, 2001; Ren et al., 2004; Kearns et al., 
2005; Chu et al., 2006; Branda et al., 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Suggested mechanism for lutABC operon using L-lactate which under 
the repressing control of YvfI and SinR cooperator genes. L-lactate tends 
to interaction with YvfI hence, operon is derepressed. 
1.4 Hypothesis 
It has been previously suggested that YvfI and SinR seem to act cooperatively to 
repress lutABC (Chai et al., 2009). Besides to lutABC operon ,  in our previous study 
tapA operon and aprE were found to be under direct control of YvfI (İrigül-Sönmez 
Ph.D. Thesis, 2012). Those genes  were previously published to be directly regulated 
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by SinR (Chu et al., 2006). Consequently, it was tested whether SinR would interact 
with the regulatory regions of all or only some YvfI-target genes and/or they would 
affect each other’s binding. For this, we employed Electro Mobility Shift Assay 
(EMSA) analysis with the regulatory regions of all of the YvfI-target genes identified 
previously (İrigül-Sönmez, Ph.D. Thesis, 2012).  
Furthermore, DegU protein had regulatory  effect on yvfI gene (Ünlü M.Sc. Thesis, 
2009). Accordingly with these foresights, Electro mobility shift assay (EMSA) 
analysis was performed  in order to determine possible direct interaction of DegU 
protein with the regulatory region of the yvfI  gene.  
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2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Bacterial strains 
Strains used throughout this study and their genotypes are listed in Table 2.1. As 
wild type strain, Bacillus subtilis PY79 was used.  
Figure 2.1 shows pGEM-T vector that was used for cloning of PCR products and 
Figure 2.2 shows pQE60 vector that was used for the expression of desired proteins. 
Table 2.1 : Bacterial strains and their genotypes used in this project. 
 
Strains Genotype Source 
 
B. subtilis PY79  
 
 
 
wild type, BSP cured prototrophic 
derivative of B.subtilis 168  
 
P.Youngman  
 
 
 E. coli DH5α  
 
 
F’ ФdlacZ (lacZY AargF), 
U169,supE44λ-,thi-1,gyrA,recA1, 
relA1 endA1, hsdR17 ] 
 
American Type 
Culture Collection; 
Hanahan (1983) 
 
  pHis6-degU  
 
 
DegU in pQE60  
 
 
T. E. Köroğlu  
 
 
  pHis6-sinR                     SinR in pQE60                                    This study 
 
 
  pHis6-YvfI                     YvfI in pQE60                                      Ö. İrigül Sönmez    
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Figure 2.1: Genomic map of the pGEM-T vector 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Genomic map of the pQE60 expression vector. 
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2.1.2 Bacterial culture media 
Compositions and preparation techniques of culture media are given in Appendix C. 
2.1.3 Buffers and solutions 
Compositions and preparation of buffers and solutions are given in Appendix D. 
2.1.4 Chemicals and enzymes 
Chemicals and enzymes that were used in this study are given in Appendix E. 
2.1.5 Laboratory equipment 
Laboratory equipment used troughout the study is listed in Appendix G. 
2.1.6 Maintenance of bacterial strains 
E. coli and B. subtilis strains were grown in Luria-Bertani (LB) liquid medium and 
kept on Luria-Bertani (LB) agar plates at +4 
○
C. All strains were subcultured at 30 
days intervals. 10% LB glycerol stock was prepared for each strain and stocks were 
kept for extended storage at -80°C. Amp (100 μg/ml) was used for E.coli DH5α strain 
for selection with antibiotic. 
2.2 Methods 
2.2.1 DNA techniques and manipulation 
2.2.1.1. Plasmid DNA isolation 
Qiagen Plasmid Purification Mini Kit (Qiagen Inc., Valencia, CA) was mostly used 
for isolation of E. coli plasmid DNA. Bacterial cells which were cultured overnight 
in LB medium at 37
o
C, were harvested by centrifugation at 13.000 rpm for 5 
minutes. After removing supernatant, the pellet was resuspended by vortexing in 330 
μL P1 buffer (Appendix D). Then, solution mix was added with 330 μL P2 
(Appendix D) buffer and mix was then incubated at room temperature for 5 minutes. 
After incubation time, 330 μL P3 (Appendix D) buffer was added and solution mix 
through inverting the tubes until the lysate is no longer viscous. The sample was 
incubated on ice for 15 minutes. Following centrifugation at 13.000 rpm for 15 
minutes, 900 μL supernatant was transferred to a new 1,5 mL eppendorf tube. 
Plasmid DNA was precipitated following the addition of 0,7 volume (630 μL) 
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isopropanol and centrifugated at 13.000 rpm for 30 minutes. Supernatant removed. 
Then, DNA containing pellet was washed with 1 mL 70% ethanol. Ethanol was 
evaporated at 37
 ◦C for 15 minutes. As last step, the pellet was dissolved in 15 μL 
elution buffer (EB) and shaked at 200 rpm at 37
◦
C, and stored at -20
◦
C. The isolated 
DNA was run on 1 % agarose gel. 
2.2.1.2 Chromosomal DNA isolation  
Chromosomal DNA’s of B. subtilis strains were isolated and purified by using a 
standart procedure designed for Bacillus species (Cutting and Horn, 1990). 1,5 mL of 
overnight culture of Bacillus subtilis PY79 strain was harvested by centrifugation at 
13.000 rpm for 5 minutes. Supernatant was discarded and obtained pellet was 
resuspended in 567 μL of TE buffer (Appendix D). 10 μL of proteinase K (20 
mg/mL), 6 μL of RNase (10 mg/mL), 24 μL of lysozyme (100 mg/mL) and 30 μL of 
10% SDS were added respectively to the cell mixture and homogenized mixture was 
incubated for 1 hour at 37°C in a water bath or thermomixer. Then, 100 μL of 5M 
NaCl solution and 80 μL of CTAB/NaCl  solution (Appendix D) (it must prewarmed 
to 65
o
C because of viscosity) were added and the sample was incubated for 10 
minutes in 65°C water bath or thermomixer. Freshly prepared 
phenol/chloroform/isoamyl alcohol (25:24:1) was then added to the mixture in same 
volume and it was centrifuged at 13000 rpm for 15 minutes. After centrifugation, the 
upper phase was transferred to a new 1,5 mL microfuge tube and 0,7 volume 
isopropanol was added. After gently mixing, the sample was centrifuged at 13000 
rpm for 15 minutes. The supernatant was removed and the pellet was washed with 1 
mL 70% ethanol and centrifuged at 13.000 rpm for 5 minutes. Subsequently, pellet 
was dried at 37°C for 1 hour and dissolved in 10 μL of TE buffer. Samples stored at 
room temperature overnight, after this time obtained chromosomal DNA was stored 
at 4°C. 
2.2.1.3 Polymerase chain reaction (PCR) 
The sequences of primers which were used for EMSA assays of SinR-YvfI co-
regulated genes used in PCR reactions were listed in the Appendix B. i-Taq 
polymerase supplied by iNtRON Biotechnology was used for PCR. PCR conditions 
were listed in Table 2.2. PCR components and amounts used in reaction are given in 
Table 2.3. 
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On the other hand, Expand High Fidelity PCR System (Roche) was prefered for the 
construction of pHis6-sinR.  The oligonucleotide primers of SinR were listed in Table 
2.4 and  Expand High Fidelity PCR reaction components and amounts are given in 
Table 2.5.  
Table 2.2 : i-Taq PCR conditions 
  Temperature Time Cycle 
        Initial denaturation             94 
o
C                 3’ 
        Denaturation        94 
o
C                 1’ 
        Annealing           *                     1’           5 cycles 
                    Extension        72 
o
C                 1’   
                    Denaturation        94 
o
C                 1’  
        Annealing           *                     1’            25 cycles 
        Extension        72 
o
C                 1’   
        Final extension        72 
o
C                15’ 
 
 *: 38 different genes were used in this study. Therefore, annealing temperatures of 
these genes show differences because of their dissimilar sequences. 
Table 2.3 : i-Taq PCR components and amounts  
                 Component Amount (50 μL in total) 
                 10X Buffer                                             5 μL 
                 dNTP                                                 5 μL 
                    Template                                                             1 μL 
                    Reverse primer                            1 μL 
                    Forward primer                                                   1 μL 
                    i-Taq polymerase                                                0,5 μL 
                    dH2O                                                                   36,5 μL 
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Table 2.4 : Oligonucleotide primer sequences of sinR  
          Primer Oligonucleotide sequences 
            sinR BamHI - reverse    GCCGGATCCCTCCTCTTTTTGGGATTTTCT    
            sinR NcoI - forward      CGGCCATGGGTTTGATTGGCCAGCGTCTTAAA 
 
Table 2.5 : Expand High Fidelity PCR reaction components and amounts 
                 Component Amount (50 μL in total) 
                 10x Buffer with MgCl2                                        5 μL 
                 dNTP (2,5mM)                                                 4 μL 
                    Template                                                             1 μL 
                    Reverse primer                            1,5 μL 
                    Forward primer                                                   1,5 μL 
                    Enzym mix                                                          0,75 μL 
                    dH2O                                                                   36,25 μL 
2.2.1.4 Polymerase chain reaction (PCR) for sequencing 
PCR components which were used for sequence PCR and amounts of ingredients are 
given in Table 2.6.  
The sequence of M13 reverse primer used for Sequence PCR was given below. 
 5’- AGC GGA TAA CAA TTT CAC ACA GGA -3’ 
Table 2.6 : Components and amounts used for Sequence PCR. 
          Component     Amount (10 μL in total) 
            5X Sequencing Buffer                                                         2 μL 
            Big Dye Terminator v3.1                                                     2 μL 
            Template                                                                             1 μL 
Primer (10 pmol)                                                                 1 μL  
dH2O                                                                                   4 μL  
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Following PCR for sequence analysis, 25 μL ethanol and 1 μL of sodium acetate 
solution was mixed. 10 μL of PCR product was added into the mixture and it was 
incubated on ice for 15 minutes. The mixture was then centrifuged at 14000 rpm for 
15 minutes. Supernatant is discarded and 250 μL of ethanol was used in order to 
wash the pellet. The mixture was centrifuged at 14000 rpm for 15 minutes. 
Supernatant is discarded once again and the pellet was dried off from ethanol 
residues completely by incubating at 95
o
C for 3 minutes. Finally, 20 μL formamide 
was added onto the DNA pellet and incubated at 95
o
C for 3 minutes and then 
vortexed. After denaturation with formamide, the sample was incubated at -20
o
C for 
2-3 minutes. 
In order to perform sequence analysis, Avant 3130 Genetic Analyzer (POP7 polymer 
with a capillary array length of 50 cm) together with the particular components 
provided by Applied Biosystems (ABI) were used.  
2.2.1.5 Agarose gel electrophoresis  
Agarose gels which have different concentration were used according to the different 
samples. These concentrations were given Table 2.3. Electrophoresis was carried out 
on a horizontal submarine electrophoresis apparatus and in a gel system composed of 
~1% agarose gel containing 1xTAE buffer (Appendix D) and ethidium bromide of a 
0.2 μg/mL final concentration. 1X Loading dye was added into the samples 
Electrophoresis was performed at 90-120 Volts for 30-35 minutes. The DNA bands 
were visualized on a shortwave UV transilluminator (UVP) and photographed by 
using Gel Imaging System. GeneRuler DNA Ladder Mix marker (Appendix D) were 
used to determine the molecular weights of DNA bands for desired purposes. 
2.2.1.6 Gel extraction 
Desired DNA fragments were extracted from agarose gel and purified by using 
“QIAquick  Gel  Extraction  Kit”  (Qiagen Inc., Valencia, CA) according  to  the  
manufacturer’s protocol.  After obtaining DNA, an aliquot was run on 1 % agarose 
gel to monitor the final DNA concentration and stored at -20°C.   
2.2.1.7 Ligation of PCR products into pGEM®-T easy vector 
Ligation of PCR products to pGEM®-T Easy Vector protocole was given in Table 
2.7. 
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Table 2.7 : Ligation components and amounts 
          Component     Amount (10 μL in total) 
          2X Rapid Ligation Buffer 
                            +                 
                 T4 DNA Ligase                                    
                  5 μL 
            pGEM
®
-T Easy Vector (50 ng/μL)                                    1 μL 
            Insert DNA (PCR product)                                                2 μL 
            dH2O                                                                                 2 μL  
 
Components of  Ligation of PCR products into pGEM
®
-T easy vector were mixed in 
a microfuge tube. Reaction mixture was incubated overnight at 4
◦
C to maximum 
number of transformants) After ligation was completed, the mixture was used to 
transform chemical-competent E. coli DH5α cells. 
2.2.1.8 Ligation of pQE60 expression vector  
Ligation procedure for clonning into the pQE60 expression vector was carried out 
using 8 μl sample of DNA fragment containing sinR gene as insert and 2 μl of 
pQE60 vector. Vector and fragment were  mixed  in  a  clean  eppendorf  tube  and 
incubated for 10 min at 65°C. Then, the tube was cooled on ice. Following cooling 
step, components that are given at Table 2.8 were added to the same eppendorf tube. 
Eventually,  the  mixture  was  centrifuged  for  a short spin and incubated at 16°C 
for 16 h. 
Table 2.8 : Components and amounts of ligation of pQE60 expression vector 
                Component Amount (20 μL in total) 
                DNA fragment (insert)                                              8 μL 
                pQE60 (vector)                                                     2 μL 
                  10X Ligation Buffer                                                 2 μL 
                  Polyethylen glycol (50% PEG 8000)                       2 μL 
                  T4 DNA ligase                                                         2 μL 
                  dH2O                                                                        4 μL 
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2.2.1.9 Restriction enzyme digestion 
Restriction enzymes were held in a suitable buffer that the amount of 10X digestion 
buffer was 1/10 of the total reaction mix. The reaction mix was incubated at 37°C for 
1-4 hours, later on enzyme was denaturated at 65°C for 10 minutes. The sample was 
stored at -20
o
C until needed. 
2.2.2 Transformation 
2.2.2.1. Preparation of E.coli DH5α CaCl2 competent cells  
E. coli competent cells were prepared according to the protocol described by 
Sambrook et al. (1989) with some modifications. E.coli cells from a fresh LB agar 
plate were inoculated in 50 μL falcon that has 5 mL of LB broth (Appendix C) as 
pre-culture and incubated overnight with shaking at 37°C. When cells reach to 
stationary phase, 500 μL cells were transferred into a new sterile 250 μL flask 
containing 50 mL LB broth. The culture was incubated for 2.5-3 hours at 37 °C in 
shaker until exponentially growing culture was obtained. Following, culture was split 
to half into two sterile pre-chilled 50 mL falcon (Total 2 falcon) and stored on ice for 
10 minutes. Then cells were centrifuged at 4,000 rpm for 10 min at 4 °C and 
supernatants were removed. Pellets were resuspended with 10 mL 100 mM cold 
CaCl2 (pH 7.0-filtered) by pipeting and held on ice for 30 min. The cells were spun 
down at 4,000 rpm for 10 min at 4°C. Finally, supernatants were removed and each 
pellet was resuspended gently in 1,25 mL cold 75 mM CaCl2. Subsequently, 138 μL 
sterile 10% glycerol were added and cells were aliquoted to be 111 μL in 1,5 mL 
sterile eppendorf tubes and as last step the competent cells were stored at – 80°C.  
2.2.2.2 Transformation of CaCl2 competent E.coli  DH5α cells 
For transformation, competent E. coli cells were kept on ice for 15 min. 10 μL of 
ligation products was added to the competent cells and mixed gently. The mixture 
was incubated on ice for 20 min. then heat shock was applied at 42°C for 45 sec and 
the tube was incubated on ice for 5 min. 1 mL of LB was added to the mixture and 
incubated at 37°C or 1-1,5 h in shaker . The cells were microfuged at 5,000 rpm for 
5-10 min and 1 ml supernatant was discarded. Subsequently, pellet was resuspended 
with remaining supernatant. Following this, mixture was transferred to plate that has 
selective medium containing appropriate antibiotic (100μg/mL ampicillin) by 
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spreading method. For blue-white colony selection, they were plated on LB agar 
media containing 80 mg/mL X-gal, 0.5 mM IPTG and 100μg/mL ampicillin. 
2.2.3 Protein synthesis  
2.2.3.1 Purification of 6xHis-tagged proteins from E. coli under native 
conditions  
Overexpression of histidine tagged proteins in E.coli  
50 mL overnight pre-culture of E.coli DH5α carrying the desired protein sequences 
in pQE60 expression vector was transferred into 1 L LB broth medium which 
contains Amp (100 μg/ml) as selective antibiotic. Culture was incubated at 37 oC 
shaking with 200 rpm until reached to 0.6 of OD600. Following, 1 ml of bacterial 
sample was transferred to a microcentrifuge tube and harvested by centrifugation at 
13000 rpm for 1 minute as uninduced sample. Then 1mM of IPTG was 
supplemented into bacterial culture and it was incubated at 37 
o
C shaking with 200 
rpm for 5 hours. At the end of this time, 1 ml of induced cell sample was taken into a 
microcentrifuge tube and harvested by centrifugation at 13000 rpm for 1 minute as 
induced sample. Remaining bacterial cell culture was harvested by centrifugation at 
5000 rpm for 10-15 minutes. After removal of supernatant, pellet was resuspended in 
2 ml Lysis buffer (Appendix D). Cell culture was stored at -80 
o
C.  
Purification of 6xHis-tagged proteins expressed in E.coli   
In order to disrupt the cells, after the freeze-thaw, lysozyme (1 mg/ml) treatment was 
performed at + 4 
o
C. Following, sonication was applied at 50 watt for 7-10 minutes. 
After sonication, the cell lysates were centrifuged for 15 min at 15,000 rpm to 
remove the insoluble materials and the supernatant was transferred to a fresh 1,5 mL 
eppendorf tube. To immobilize the proteins, Ni-NTA resin (10 μl resin has a capacity 
for 50–100 μg 6xHis-tagged protein) was added at the ratio of 10:1 to each 
microcentrifuge tube containing 1ml supernatant. Upper phase which contain alcohol 
was discarded and lysis buffer (Appendix D) was added. The mixture (the 
supernatant and resin) was gently rotated for 45 minutes at + 4°C in rotator. After 
that, samples were centrifuged for 1 min at 1000 rcf  to precipitate the resin. Resin 
pellets were washed three times with 1 ml 20 mM wash buffer and one time with 1 
ml 50 mM wash buffer (Appendix D). After washing steps, his6-proteins were eluted 
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with 100 μl elution buffer (Appendix D) 1-2 times. Histidine tagged proteins were 
eluted against imidazole concentration under native conditions. 
2.2.3.2 SDS-PAGE analysis  
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) or 
denaturing gel electrophoresis was applied in order to monitor the purification steps, 
to determine homogeneity, purity and the relative molecular mass of the proteins. 50 
μl SDS-loading dye was added to samples and lysozyme treatment was applied for 
20-30 min at + 4 
o
C. All samples and unstained protein marker were denatured at 
99°C for 5 min.  SDS-PAGE was carried on a 15% separating gel and a 4% stacking 
gel (Table 2.9) according to the protocol of Laemmli (1970).  
Molecular weight of the proteins were determined by comparing their profiles with 
unstained protein molecular weight marker (Fermentas) (Appendix D).  
After denaturation, samples were loaded onto SDS-PAGE gel and run at 80V for 20-
30 min until the samples pass the separating gel and later on voltage was increased 
120V for 2-3 hours. At the next step, polyacrylamide gels were stained with SDS-
PAGE staining solution (Appendix D) at 37°C for 1 hour and shaked gently, as last 
step gel was washed overnight with destain buffer (Appendix D), and then 
visualized. 
Table 2.9 : Preparation of SDS-gel 
               15% Separating Gel                                               for 5 mL 
               dH2O                                                                      1,15 mL 
               30% acrylamide                                                     2,5 mL 
               1,5 mM Tris pH 8,8                                               1,25 mL 
               10% SDS                                                               50 μl 
               TEMED                                                                 4 μl 
               10% APS                                                               50 μl 
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               4% Stacking Gel                                                 for 5 mL 
               dH2O                                                                   1,4 mL 
               30% acrylamide                                                  330 μl 
               1 M Tris pH 6,8                                                   250 μl 
               10% SDS                                                             20 μl 
               TEMED                                                               2 μl 
               10%APS                                                              20 μl 
 
2.2.3.3 Determination of protein concentrations with Bradford assay  
Bradford Protein Assay was used in order to determine the protein concentration 
(Bradford, 1976). In order to obtain a correct standart curve, bovine serum albumin 
(BSA) was used as standarts at different concentrations 0.125, 0.25, 0.5, 0.75, 1, 1.5, 
2 mg/ml respectively. Proteins and standart solutions were assayed in a 96 wells 
microplate. Bradford assay was performed using 5 μl of each standart solutions and 
proteins with 250 μl Bradford reagent. Color of this mixture was converted blue 
according to concentration of protein. Absorption spectrum was measured at 595 nm.  
2.2.3.4 EMSA (Electro mobility shift assay)  
Predicted promoter regions of target genes, approximately 200-350 bp upstream of 
the start codon, were amplified by PCR, using B. subtilis PY79 chromosomal DNA 
as template with specific primers given in Appendix B.  
50 mM KCl, 5 mM MgCl2, 0.1 mM EDTA, 1 mM DTT, 8% glycerol in 10mM Tris-
HCl, pH 8 (Köroğlu et al., 2008) (Appendix D); reaction buffer which was  
supplemented with competitor DNA poly [d(I-C)] (1μg/ml), BSA (0,1 μg/ml) and 45 
nanograms of promoter DNA was used for gel retardation of YvfI-SinR and DegU, 
10 mM Tris-HCl, pH 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol (DTT) 
and 5% (v/v) glycerol (Appendix D) was used as binding buffer. 25 μl total reaction 
mixtures were incubated at 37 °C for 10 minutes after that at 4 °C for 15 minutes. 
Following that, loading dye buffer [0,25xTGE, 60%; glycerol, 40%; bromophenol 
blue, 0,2%(w/v)] was added 5 μl to each reaction. 4% native polyacrylamide TGE 
gel was pre-run at 180 V for 5 minutes at 4°C. After pre-running, acquired mixtures 
were loaded 13 μl 4% native polyacrylamide TGE gel (Table 2.10) and 
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electrophoresis was run in 1x TGE buffer (Appendix D) firstly at 250 V for 4 
minutes, afterwards at 180 V for 24 minutes at 4°C and into the ice box. Following 
electrophoresis, gel was incubated at 37°C on the orbital shaker which have low rpm 
for 20 minutes with SYBR
®
 Green I Nucleic Acid Gel Stain (10,000X concentrate in 
DMSO) (Lonza) and visualized with UV-transulliminator to monitor the migrated 
DNA fragments. 
Table 2.10 : Preparation of Native EMSA gel 
                                                                                                 4% gel                                            
               dH2O                                                                         3,29 mL 
               30% acrylamide                                                        0,665 mL 
               1X TGE buffer                                                          0,5 mL 
               TEMED                                                                    4 μl 
               10% APS                                                                  62,5 μl 
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3. RESULTS AND DISCUSSION 
3.1 Construction of E.coli pSinR-His6-strain 
In order to purify SinR protein, an E.coli SinR-His6 strain was constructed. Firstly, 
sinR gene, 336 bp in length, was amplified with High Fidelity DNA polymerase 
(Figure 3.2) using chromosomal DNA of Bacillus subtilis PY79 wild type strain as 
template (Figure 3.1).  
 
 
 
 
 
 
 
Figure 3.1 : Chromosomal DNA isolated from Bacillus subtilis PY79 (line 1) and 
M; Lambda DNA/EcoRI+HindIII Marker (Fermentas) 
The primers sinR forward and reverse given below, including extra residues for NcoI 
and BamHI recognition sites (underline sequences) were used for the amplification of 
336 bp sinR gene. 
sinR NcoI-F : 5'– G C C G G A T C C C T C C T C T T T T T G G G A T T T T C T 
-3' 
sinR BamHI-R: 5'– C G G C C A T G G G T T T G A T T G G C C A G C G T A T 
T A A A-3' 
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Figure 3.2 : Amplification of the sinR gene by PCR. Lane 1-2;  336bp PCR product 
amplified by using specific primers sinR NcoI-F and sinR BamHI-R 
and PY79 chromosomal DNA as template DNA, Gene Ruler DNA 
Ladder Mix  Marker (Fermentas) (Appendix F).  
The amplified PCR product was further purified and DNA fragment was ligated into 
pGEM®-T Easy Cloning Vector and ligation mixture was used to  transform E. coli 
DH5α CaCl2 competent cells. Transformants were selected on X-gal/IPTG 
ampicillin-containing agar plates after incubation at 37 
o
C for 16 hours. Then, 
following blue-white screening, white colonies were inoculated in liquid LB+Amp 
medium and incubated overnight. Plasmids were screened with EcoRI digestion in 
order to confirm the cloning of the 336 bp insert into pGEM-T vector (Figure 3.3) 
and further confirmation was also done by DNA sequencing. 
 
 
 
 
 
 
 
 
 
Figure 3.3 : Confirmation of the cloning of the 336 bp DNA fragment into pGEM®-
T Easy Vector. Lanes 1-3-5-7; uncut plasmid, Lane 2-4-6-8; plasmids 
digested with EcoRI, M; Gene Ruler DNA Ladder Mix Marker 
(Fermentas) (Appendix F). 
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Isolated pGEM-T-sinR recombinant plasmid and pQE60 expression vector were 
double digested with NcoI and BamHI restriction enzymes (Figure 3.4-3.5).  
 
 
 
 
 
 
 
Figure 3.4 : Restriction enzyme digestion of the sinR gene cloned into pGEM®-T 
Easy Vector. The sinR gene fragment digested with NcoI and BamHI 
restriction enzymes, M; Gene Ruler DNA Ladder Mix (Fermentas) 
(Appendix F).  
 
 
 
 
 
 
Figure 3.5 : Digestion of the pQE60 expression vector by NcoI and BamHI 
restriction enzymes, M; Gene Ruler DNA Ladder Mix (Fermentas) 
(Appendix F).  
Furthermore, NcoI and BamHI digested sinR fragment from pGEM
®
-T Easy and 
pQE60 expression vector were extracted from agarose gel and ligated together with 
T4 ligase overnight at 4 
o
C. After that, ligation product was used to transform CaCl2 
competent E. coli DH5α cells and colonies were selected on LB+Amp containing 
agar plates. Plasmid DNAs were isolated from transformants and digested with NcoI 
and BamHI restriction enzymes in order to confirm the cloning of 336 bp sinR gene 
into pQE60 (Figure 3.6) 
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Figure 3.6 : Confirmation of the colonies bearing sinR gene in pQE60 expression 
vector via NcoI and BamHI restriction enzyme digestion, M; Gene 
Ruler DNA Ladder Mix (Fermentas) (Appendix F).  
3.4 Overexpression of SinR-His6 proteins in E.coli  
Recombinant E. coli strain carrying the pQESinR expression vector were grown in 
50 mL of LB medium and they were transferred into 1 L of LB medium containing 1 
mL ampicillin (100 μg/ml). At the beginning of the exponential phase (OD600/0,6) 
growing cells were induced with 1mM IPTG to overexpress proteins. After 5 hours 
incubation period, cells were divided to 3 Beckmann centrifuge tube and harvested 
by centrifugation at 5000 rpm for 10 minutes. Pellets were resuspended in 2 ml lysis 
buffer and stored at -80 
o
C. 
3.5 Purification of SinR-His6 proteins  
Ni-NTA resin (Qiagen) was used in order to purify SinR protein. Initially, cells were 
lysed with lysozym and sonication. The culture was cleared by centrifugation at 
15,000 rcf for 15min at 4
o
C and the cell extracts were treated with Ni-NTA resin in 
rotator for 45 minutes. After treatment, histidine-tagged proteins were eluted against 
increased imidazole concentration under native conditions. 
The extracted  proteins were analysed by SDS-PAGE on the basis of the molecular 
mass of the proteins. As seen in Figure 3.7 SinR-His6, is succesfully exspressed 
purified from E. coli cells. 
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Figure 3.7 : Purified SinR (12.989 KDa) protein. Washing steps (line 2,3,4,5,6), 
elutions of the purified SinR proteins (lane 7-8-9), M; Protein molecular 
mass marker (Fermentas) (Appendix F) 
3.6.2 Investigation of regulatory interaction between YvfI and SinR by EMSA  
In order to elucidate the regulatory interaction  between YvfI and SinR proteins in 
B.subtilis, 38 YvfI-target genes which have been previously found to be under direct 
control of YvfI  (Irigul-Sonmez Ph.D. thesis, 2012) were analysed whether SinR 
would interact with the regulatory regions of all or only some YvfI-target genes 
and/or they would affect  each  other’s binding.  For this,  EMSA analysis were 
employed  with the increasing concentrations of purified SinR or YvfI alone and in 
the presence of both regulators in which the fixed amount of one of them was mixed 
with the increasing concentrations of the others. To validate our EMSA analysis, 
each EMSA was repeated at least two times and the regulatory region of the 
unrelated ywbH was used as a negative control (Figure 3.8b)  while promoter region 
of lutA was used as the positive control (Figue 3.8a) (Chai et al., 2009) and all of the 
binding experiments were performed in the presence of a molar excess of poly [dI-
dC)]. Thus we ensured that observed DNA shifts were YvfI specific since YvfI 
caused no retardation in electrophoretic mobility with the regulatory region of an 
unrelated gene, ywbH .   
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Figure 3.8 : EMSA analysis performed using the promoter regions of  lutA (a)  and 
ywbH (b).  
YvfI and SinR affected genes were grouped according to their functions and  these 
genes were found to be associated with various biological processes and/or 
metabolims. i.g. nitrogen metabolism, carbohydrate metabolism, degradative enzyme 
production, antibiotic production and resistance, regulation of B. subtilis mobile 
genetic elements, sporulation, cannibalism and sporulation delay, biofilm formation, 
cell membrane stress, activation of phage related genes, potassium uptake as 
explained below. 
3.6.2.1 Nitrogen metabolism 
Glutamine and glutamate are two central intermediates of nitrogen metabolism in 
bacteria. Their intracellular levels are vital for nitrogen metabolism modulation. 
Glutamine and glutamate serve as the main nitrogen source in the cell (Fisher & 
Sonenshein, 1991).  
gltA (encoding glutamate synthase large subunit)and gltB (encoding glutamate 
synthase (NADPH) small chain) are two essential genes for nitrogen metabolism. 
The  transcriptional level of these genes were found to be down-regulated by YvfI in 
early stationary phase cells. In  this study, gltAB operon was found to be directly co-
regulated byYvfI  and SinR   since both YvfI and SinR alone was able to produce a 
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mobility shift with the regulatory regions (Figure 3.9). They exhibit additive or 
simultaneous binding since addition of increased amount of YvfI in the presence of 
fixed amount of SinR or addition of increased amount of SinR in the presence of 
fixed amount of YvfI resulted in an additional retardation in the electrophoretic 
mobility of SinR-bound or YvfI bound-DNA probes,  
Transcription of all genes associated with arginine biosynthesis 
(argCJBDcarABargF and argGH) and tryptophane biosynthesis (trpEDCGBA) are 
connected to enhanced expression of gltAB and glnRA operons. While glnR encodes 
for a nitrogen regulatory protein, glnA encodes for a glutamine synthase. As  in the 
case of gltAB operon, purified YvfI-His6 and SinR-His6 acted directly on promoter 
region of glnRA operon. They exhibited  additive or simultaneous binding to the 
regulatory regions of the gltA and glnR genes (Figure 3.9a,b) 
The pyrimidine nucleotide biosynthetic (pyr) operon (pyrB-pyrC-pyrAA-pyrAB-
pyrK-pyrD-pyrF-pyrE) was found to be directly controlled by  YvfI and SinR since 
both YvfI and SinR alone was able to produce a mobility shift with the regulatory 
regions and they exhibited  an additive or simultaneous binding to the regulatory 
region of pyrB  (Figure 3.9d). 
As discovered previously, expression of the pyr operon is repressed by PyrR via 
formation of a terminator hairpin in B. Subtilis (Lu & Switzer, 1996). In addition to 
PyrP-directed negative control, pyr operon was found to be under positive control 
directed by YvfI and also co-regulated with SinR (Figure 3.9e). 
a 
b 
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Figure 3.9 : EMSA analysis performed using the promoter regions of the gltA, glnR, 
argG, pyrB, pyrR genes. Assays were performed with increasing 
concentrations of YvfI both in theabsence of SinR and in the presence 
of 3 µM of SinR and increasing concentrations of SinR both in the 
absence of YvfI and in the presence of of 3 µM YvfI.    
According to these findings, YvfI and SinR proteins were found to be required for 
the regulation of nitrogen metabolism by acting both in a negative and positive 
manner and furthermore they have exerted additive or simultaneous binding to the 
promoter regions of pyrB and pyrR. 
3.6.2.2 Carbohydrate metabolism 
According to previous findigs, YvfI-controlled genes (lutABC) were found to be 
necessary for the growth of  organism on L- lactate as a sole carbon source and YvfI 
and SinR seem to act cooperatively to repress lutABC (Chai et al., 2009). YvfI was 
also demonstrated  to repress the acoABCL operon, encoding acetoin dehydrogenase 
complex required for acetoin utilization (Huang et al., 1999). Expression of this 
operon is subject to catabolite repression by glucose through CcpA  (Ali et al., 2001). 
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In addition to this, msmRE operon was directly downregulated by YvfI.  msmR 
encodes  a putative regulatory protein that belong to the LacI family and msmE 
encodes a binding protein for the transport of multiple sugars. 
In this study, it was shown that  SinR also participate to the regulation of 
carbohydrate transport systems besides to acetoin utilization  operon carbohydrate 
utilization systems in the early stationary phase cell and the interaction of these  
proteins were in an additive or simultaneous way (Figure 3.10). 
 
 
 
Figure 3.10 : EMSA analysis performed using the promoter regions of the acoA, 
msmR genes. Assays were performed with increasing concentrations of 
YvfI both in the absence of SinR and in the presence of 3 µM of SinR 
and increasing concentrations of SinR both in the absence of YvfI and 
in the presence of of 3 µM YvfI. 
3.6.2.3 Degradative enzyme production 
B. subtilis produces a wide variety of degradative enzymes to consume alternative 
nutrients during the transition state. In conjuction to this feature, four degradative 
enzyme encoding genes that are related to adaptation to nutrients, were found to be 
under the direct positive control of YvfI. These genes are the yhfEF operon encoding 
a putative endogluconase (Kunst et al., 1997) and the cwlO gene, encoding a cell 
wall lytic enzyme DL-endopeptidase (Yamaguchi et al., 2004; Mitsui et al., 2011) 
(Figure 3.11a,b).  In this study, SinR also directly interacted  with the regulatory 
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regions of yhfEF and cwlO. These evidences showed  thatYvfI and SinR act together  
to provide the  adaptation of cells  to the conditions of nutrient deficiency. 
Interestingly, the major intracellular serine protease IspA and the extracellular 
alkaline serine protease AprE were found to be directly down regulated by YvfI in 
B.subtilis (Figure 3.11c,d). It should be noted that other than YvfI, aprE gene is 
subject to a complex regulatory pattern; DegU activates, and AbrB, ScoC and SinR 
represses its transcription by directly binding to the promoter region (Msadek et al., 
1991; Ogura et al., 2003; Ogura et al., 2004; Abe et al., 2009). This study also 
demonstrated that  YvfI and SinR  exhibited additive or simultaneous binding to the 
regulatory regions of aprE and ispA.  
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Figure 3.11 : EMSA analysis performed using the promoter regions of the yhfE, 
cwlO, aprE, ispA genes. Assays were performed with increasing 
concentrations of YvfI both in the absence of SinR and in the presence 
of 3 µM of SinR and increasing concentrations of SinR both in the 
absence of YvfI and in the presence of of 3 µM YvfI 
3.6.2.4 Antibiotic production and resistance 
YvfI displays a positive regulatory effect on the non-ribosomally synthesized 
lipopeptide antibiotic fengycin (plipastatin) and polyketide antibiotic production. 
EMSA analysis performed in the presence of promoter regions of the pps operon 
which plays an active role on antibiotic fengycin-plipastatin production, 
demonstrated that YvfI directly binds to the regulatory  region of ppsABCDE operon 
In this study SinR also directly interacting with the regulatory region  of pps operon 
(Figure 3.12a). 
In parallel with the previous study (Köroğlu et al., 2008) in which dipeptide 
antibiotic bacilysin production was negatively affected from the inactivation of yvfI 
gene. Consequently, EMSA analysis highlighted that  YvfI and SinR are 
coregulatory proteins directly affeced the transcription of the bacABCDEywfG 
operon and the ywfH gene. (Figure 3.12b,c) 
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Figure 3.12 : EMSA analysis performed using the promoter regions of the ppsA, 
bacA, ywfH, yydF, yokD genes. Assays were performed with increasing 
concentrations of YvfI both in the absence of SinR and in the presence 
of 3 µM of SinR and increasing concentrations of SinR both in the 
absence of YvfI and in the presence of of 3 µM YvfI. 
According to previous studies, yydFGHIJ operon is responsible for the synthesis, 
modification, cleavage, and export of this small modified antimicrobial peptide YydF 
(Butcher et al.,2007) (Figure 3.12d). Hoffman et al. (2005)  reported that  the yokD 
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gene encodes a putative aminoglycoside acetyltransferase which might be a 
component of the bacterium's aminoglycoside resistance mechanism.  EMSA 
analysis performed  in this study  revealed that  YvfI and SinR together directly 
affect the transcriptions of the yydFGHIJ operon  and the yokD gene (Figure 3.12e)  
3.6.2.5 Regulation of B. subtilis mobile genetic elements 
Auchtung et al., (2005) determined 20kb- ICEBs1 as an integrative and conjugative 
element belonging to Bacillus subtilis and identified two proteins which are encoded 
by ICEBs1, RapI and PhrI that provide dual regulation for the excision and transfer 
of this element depending on the increase of recipient cell amount around the host 
cells. Results of this study implied that YvfI and SinR participate to the regulation of 
rapI transcription directly (Figure 3.13).  
 
Figure 3.13 : EMSA analysis performed using the promoter regions of the rapI 
gene. Assay was performed with increasing concentrations of YvfI both 
in the absence of SinR and in the presence of 3 µM of SinR and 
increasing concentrations of SinR both in the absence of YvfI and in the 
presence of of 3 µM YvfI. 
3.6.2.6 Sporulation: Cannibalism and sporulation delay 
Sporulation in B. subtilis represents the development of a specialized cell type that 
occurs through the sequential activation and blocking of genes as a response to 
unfavorable environmental conditions (Errington, 2003). Spore development is a 
high energy demanding event and once the sequential events start, the pathway is 
usually completed. Therefore, this bacterium displays a mechanism in order to delay 
entry into sporulation through an event which is called as cannibalism (Gonzalez-
Pastor et al., 2003). In this study, YvfI and SinR affected directly sdpABC operon 
(formerly the yvaWXY) positively which is known as  “sporulation delay operon” 
(Figure 3.14a). This operon has a role in the production and export of the toxin 
protein SdpC which acts as a signaling molecule for the activation sdpRI operon. The 
SdpR protein, transcribed for  this operon also delays sporulation by activating lipid 
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catabolism and ATP-producing enzymes (Gonzalez-Pastor et al. 2003). Consistent 
with this, besides the sporulation delay operon, the expressions of atpIBEFHAGDC 
operon, the lip gene encoding extracellular lipase and the hepSmenHhepTndk 
menaquinone biosynthetic operon, which is a member of respiratory chain in 
B.subtilis that contributes to ATP formation, were found to be directly up-regulated 
by YvfI. In this study it was  shown that SinR also function in the regulation of those 
gene groups  (Figure 3.14d,e,f).   
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Figure 3.14 : EMSA analysis performed using the promoter regions of the sdpA, 
ftsE, spoIIE, atpI, hepS, lip genes. Assays were performed with 
increasing concentrations of YvfI both in the absence of SinR and in 
the presence of 3 µM of SinR and increasing concentrations of SinR 
both in the absence of YvfI and in the presence of of 3 µM YvfI. 
Furthermore, the transcription of the ftsEX operon which encodes for an ABC 
transporter, was found  to be directly regulated by YvfI and SinR in this study 
(Figure 3.14b). According to binding assays, early sporulation gene spoIIE was 
found to be co-regulated by YvfI and SinR proteins (Figure 3.14c). But, in the case 
of the spoIIE gene, YvfI apparently stimulated the binding capacity of SinR while 
SinR did not affect the binding capacity of YvfI which itself had produced a mobility 
shift at all concentrations tested in a concentration dependent manner. SinR alone 
was not capable to produce a mobility shift at 2 or 3 µM protein concentrations even 
it produced at 4 µM concentration but in the presence of 3 µM YvfI, resulted in an 
additional retardation in the electrophoretic mobility of YvfI bound-DNA probes. 
Specific inhibition of sporulation stage II genes: spoIIA, spoIIE and spoIIG by SinR 
had been reported previously (Mandic-Mulec et al., 1995) that provides an in vivo 
support for the in vitro interaction of SinR with the spoIIE regulatory region detected 
in this study. 
 
38 
a 
b 
3.6.2.7 Biofilm formation 
Biofilms constitute of an extracellular matrix that enables the cells to hold together 
and behave as a multicellular community of cells in their natural habitat (Branda et 
al., 2005; Aguilar et al., 2007).  
epsA-O operon that includes 15 genes and TasA amyloid fibers synthesized by tapA-
sipW-tasA operon are responsible for Exopolysaccharide (EPS) polymer 
biosynthesis. tapA-sipW-tasA operon were found to be directly co-regulated by YvfI 
and SinR proteins in this study (Figure 3.15b). As previously shown by Chai et 
al.(2009), lutABC operon which is participate to biofilm formation is under the dual 
control of YvfI and SinR. Furthermore, in this study, two DegU-regulated genes, the 
yvcA  gene, encoding a lipoprotein, and the bslA (formerly yuaB) gene, encoding a 
amphiphilic protein on the surface of biofilms (Kobayashi & Iwano, 2012; Hobley et 
al., 2013) were found to be directly co-regulated by YvfI and SinR (Figure 3.15a,c). 
To note that YvfI and SinR exhibited cooperative binding to the regulatory region of 
bslA. Since both YvfI and SinR apparently stimulate each other’s binding to the 
regulatory region of  bslA. Although 4 µM SinR alone could shift the regulatory 
regions of lip,  in the presence of 3 µM YvfI which itself had not shifted the DNA 
probe, almost all of the lip DNA probe was shifted even at 2  µM SinR, which itself 
had not shifted the DNA probe SinR. Similarly, in the presence of 3 µM SinR, even 
2 µM YvfI, which itself had not shifted the DNA probe, shifted all of the bslA DNA 
probe.  
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Figure 3.15 : EMSA analysis performed using the promoter regions of yvcA, tapA, 
bslA genes. Assays were performed with increasing concentrations of 
YvfI both in the absence of SinR and in the presence of 3 µM of SinR 
and increasing concentrations of SinR both in the absence of YvfI and 
in the presence of of 3 µM YvfI. 
3.6.2.8 Cell envelope stress 
In this study, many genes known in the w regulon (involved in the detoxification 
and resistance to antibiotics and other agents eliciting cell envelope stress) such as: 
ybfO (putative erythromycin esterase, having a role in erythromycin resistance), 
pbpE (encoding a penicillin binding protein,PBP4 endopeptidase), yuaF-yuaG 
(encoding a putative flotillin-like protein)-yuaI(encoding a putative acetyl-
transferase) operon,  yceCDEFGH operon (encoding putative stress adaptation 
proteins similar to tellurium resistance proteins) were found to be directly co-
regulated by YvfI and SinR (Figure 3.15) sigW itself, as well as some of the W-
dependent genes including pbpE are known to be directly repressed by the transition-
state regulator AbrB (Qian et al., 2002; Huang et al., 1999). Correspondingly, 
another AbrB-repressed two loci, the liaIHGFSR operon, which is strongly induced 
in response to cell wall acting antibiotics such as vancomycin, bacitracin and nisin by 
the LiaRS two-component system (Mascher et al., 2004) and contributes to nisin 
resistance in B. subtilis 168 (Hansen et al., 2009), and subtilisin E encoding gene 
aprE is directly regulated by YvfI and SinR. Taken together, these findings point out 
to a significant overlap between the YvfI, SinR and AbrB regulons. 
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Figure 3.16 : EMSA analysis performed using the promoter regions of ybfO, pbpE, 
yuaF, yceC, liaI, bceA genes. Assays were performed with increasing 
concentrations of YvfI both in the absence of SinR and in the presence 
of 3 µM of SinR and increasing concentrations of SinR both in the 
absence of YvfI and in the presence of of 3 µM YvfI. 
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3.6.2.9 Activation of phage related genes 
It was previously shown by São-José et al. in 2004 that the yukE, yukD, yukC, yukAB 
and yueB genes are part of an operon which has a part in the irreversible adsorption 
of SPP1 (São-José et al., 2004). Another study demonstrated that the yukE operon is 
significantly induced as a response to nutrient depletion during the transition state in 
B. subtilis (Blom et al., 2011). Hence, considering the fact that YvfI and SinR 
directly interact with  the promoter region of yukE, it can be speculated that YvfI and 
SinR seems to be directly participating in the regulation of nutritional limitation 
responce (Figure 3.16).  
 
Figure 3.17 :  EMSA analysis performed using the promoter region of yukE gene. 
Assay was performed with increasing concentrations of YvfI both in the 
absence of SinR and in the presence of 3 µM of SinR and increasing 
concentrations of SinR both in the absence of YvfI and in the presence 
of of 3 µM YvfI. 
3.6.2.10 Potassium uptake: the czcD-trkA operon 
CzcD protein which belongs to CDF family of membrane transporters, plays an 
active role at antiport mechanisms catalyzing active efflux of Zn
2+
, and additionally 
Co
2+
 and Cd
2+
, in exchange for K
+
 and H
+ 
in B. subtilis. 
 
(Guffanti et al., 2002). 
Furthermore, TrkA boosts the activity of CzcD. According to the results of EMSA 
analysis, both czcD and trkA were found to be co-regulated by YvfI and SinR 
together (Figure 3.17). They exhibited additive or simultaneous binding to the 
regulatory regions of the czcD gene. 
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Figure 3.18 : EMSA analysis performed using the promoter region of the czcD gene. 
Assay was performed with increasing concentrations of YvfI both in the 
absence of SinR and in the presence of 3 µM of SinR and increasing 
concentrations of SinR both in the absence of YvfI and in the presence 
of of 3 µM YvfI. 
3.7 Identification of the regulatory effect of  DegU on yvfI gene expression  
DegS and DegU are sensor and effector proteins which are transcribed from sacU  
locus. They have a two-component signal transduction regulatory system (Stock et 
al., 1989). They play an active role in the production of many types of commercially 
valuable degradative enzymes such as extracellular proteases, α-amylase, proteases, 
intracellular serine protease and levansucrase, etc. (Tanaka et al., 1991).  
DegU, as a response regulator, is responsible for degredative enzyme synthesis. In 
addition to this, it participates in competence devolopment in Bacillus subtilis. When 
the ComK concentration is low, unphosphorilated DegU efficiently binds to the 
comK promoter in order to stimulate the binding of ComK at the onset of 
competence development (Hamoen et al., 2000; Hameon et al., 2003; Susanna et al., 
2006).  
In order to explore possible effects of the response regulator DegU on the expression 
of yvfI, gel retardation assay was performed. As shown in Figure 3.18 yvfI promoter 
fragment was shifted apparently with the increased amount of DegU-His6 
concentration. This finding revealed that response regulator DegU which contributes 
to the regulation of yvfI gene expression by directly binding to the yvfI promoter 
region. 
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Figure 3.19 : Gel retardation assay performed with yvfI promoter fragment incubated 
with purified DegU-His6 at the indicated concentrations.BSA also 
represents the negative control of the reactions where only 10 mg/ml 
BSA was used as the candidate protein. All of the binding reactions 
contain 45 ng/µl of yvfI promotor DNA and 1mg/ml poly[d(I-C)]. 
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4.CONCLUSION 
The results of the EMSA analysis performed in this study showed that SinR is 
capable to interact with the regulatory regions of all of the YvfI-target genes tested, 
but they exhibited variations in the nature of their interactions. (i) they apparently 
stimulate each other’s binding to the regulatory regions of lip and bslA. (ii) They 
exhibit additive or simultaneous binding to the regulatory regions of acoA,argG, 
aprE, atpI, bacA, bceA, czcD, cwlO, ftsE, glnR, gltA, hepS, ispA, liaI, msmR, mraY, 
pbpE, ppsA, pyrB, pyrR, rapI, sdpA, tapA, ybfO, yceC, ydjM, yneN, yhfE, ywfH, 
yuaF, yukE, yvcA, yokD, yydF, yybN. (iii) In the case of the spoIIE gene, only YvfI 
appearently stimulates the binding capacity of SinR Conclusively, our overall data 
discovered a close relationship between the YvfI and SinR regulators. Most likely 
they collectively fine-tune the level and timing of expressions of genes involving in 
postexponential-phase processes as an important part of complex interconnected 
regulatory system. In this study,  regulatory effect of responce regulator DegU 
protein on YvfI gene was also studied by  Electromobility Shift Assay (EMSA) 
method. It was found that yvfI gene itself is under the direct control of DegU in B. 
subtilis.  
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APPENDIX A 
Genes that are up (A)-  and down (B)- regulated by YvfI during early-stationary 
phase (OD6007) 
 
Gene 
 
Fold 
difference a 
qPCR b Function Transcriptional Organisation c 
     
aprX 1,57 2,98(±0,17)  serine protease  
ǂ      ⃖                                               ǂ      ⃖          
atpI 1,19  0,56(±0,03) ATP synthase subunit I  
atpB  1,93  ATP synthase subunit A   
 
ǂ      ⃖             ⃖               ⃖                ⃖               ⃖           
      ⃖               ⃖               ⃖               ⃖        ǂ 
 
atpE  2,02 1,53(±0,15) ATP synthase subunit C 
atpF  1,99  ATP synthase subunit B 
atpH  1,93  ATP synthase subunit delta 
atpA  2,01 1,13(±0,10) ATP synthase subunit alpha 
atpG  1,91  ATP synthase subunit gamma 
bioW 1,99 1,46(±0,06) 6-carboxyhexanoate--CoA ligase  
 
     ⃖       ǂ      ⃖               ⃖               ⃖               ⃖          
     ⃖            ǂ      ⃖                            
 
bioA 1,38   adenosylmethionine--8-amino-7-
oxononanoate transaminase 
bioF 1,45  8-amino-7-oxononanoate synthase 
bioD 2,06  dithiobiotin synthetase   
bioB 0,36   biotin synthase  
czcD* NR 2,25(±0,22) potassium/proton-divalent cation 
antiporter 
 
     ⃖                          ǂ      ⃖               ⃖          ǂ      ⃖          ǂ 
trkA(czcO)* 1,76 1,02(±0,06) potassium uptake oxidoreductase 
lip(estA) 2,38 2,65(±0,09) secreted alkaliphilic lipase ǂ      ⃖               ⃖                         ǂ            ǂ      ⃖         ǂ  
fabHA 1,87 1,00(±0,12) 3-oxoacyl-(acyl carrier protein) 
synthase III 
 
                        ⃖                                                ǂ                 
 
fabF 1,89  3-oxoacyl-(acyl carrier protein) 
synthase II 
fabHB 3,00 1,98(±0,05) 3-oxoacyl-(acyl carrier protein) 
synthase III 
                ǂ       ⃖                              ǂ      ⃖                            
ylxM 1,32   hypothetical protein, DNA-binding 
protein 
          ǂ                           ǂ      ⃖                                       ǂ 
Ffh 1,51 2,91(±0,04) signal recognition particle-like (SRP) 
GTPase 
ftsE 1,11 1,94(±0,13) cell-division ABC transporter (ATP-
binding protein) 
 
      ⃖          ǂ      ⃖                ⃖          ǂ      ⃖              ⃖        ǂ 
 
ftsX 1,68  cell-division ABC transporter 
hepS  1,35  0,91(±0,18) Heptaprenyl diphosphate synthase 
component I 
 
ǂ     ⃖             ⃖                ⃖                 ⃖                ⃖           
     ⃖           ǂ     ⃖       ǂ        ⃖              ǂ 
 
hepT   1,52  Heptaprenyl diphosphate synthase 
component II 
Ndk 1,37  1,01(±0,24) nucleoside diphosphate kinase 
(purine nucleotide biosynthesis) 
mraY 1,45 1,20(±0,06) phospho-N-acetylmuramoyl-
pentapeptide-transferase 
ǂ                                                                            ǂ 
                    
 
murD 1,53  UDP-N-acetylmuramoyl-L-alanyl-
D-glutamate synthetase 
pksD 1,9 1,44(±0,06) enzyme involved in polyketide 
synthesis 
 
 
 
                ǂ                                                                   
pksE 1,59  enzyme involved in polyketide 
synthesis 
acpK 1,77  acyl-carrier protein 
58 
pksG 2,10 1,42(±0,18) acetyl-S-AcpK beta-ketothioester 
polyketide intermediate transferase 
                                ǂ                                                  
 
                                                                                   ǂ  
      ⃖                           
 
pksH 0,42   enzyme involved in polyketide 
synthesis 
pksI* 0,36   enzyme involved in polyketide 
synthesis 
pksJ 2,73 4,14(±0,01) polyketide synthase of type I 
pksL 3,95 6,19(±0,06) polyketide synthase of type I 
pksM 2,17  polyketide synthase 
pksN 2,96  polyketide synthase of type I 
pksR 2,46  polyketide synthase 
ppsA* NR   plipastatin synthetase  
ǂ      ⃖                ⃖               ⃖               ⃖                ⃖           ǂ 
  
ppsB 1,1  1,09(±0,18) plipastatin synthetase 
ppsC*  NR  plipastatin synthetase 
ppsD 1,24   plipastatin synthetase 
ppsE 2,42  plipastatin synthetase 
pyrR 2,52 2,79(±0,32) bifunctional pyrimidine regulatory 
protein PyrR uracil 
phosphoribosyltransferase 
 
 
 
 
 
 
 
ǂ                   ǂ                   ǂ                                   
                                                                                           
                ǂ                 
 
pyrP* NR 3,48(±0,18) uracil permease 
pyrB  1,37 4,34(±0,01) aspartate carbamoyltransferase 
catalytic subunit 
pyrC  1,89  Dihydroorotase 
pyrAA  2,31 5,85(±0,20) carbamoyl-phosphate synthetase 
(glutaminase subunit) 
pyrAB 2,00  carbamoyl-phosphate synthetase 
(catalytic subunit) 
pyrK 0,85   dihdrooratate dehydrogenase 
pyrD 1,32   dihdrooratate dehydrogenase  
(catalytic subunit) 
pyrF 1,21   orotidine 5'-phosphate decarboxylase 
pyrE 1,08   orotate phosphoribosyl transferase 
Rnc 2,41 
 
 
1,64(±0,03) ribonuclease III, cleaves both 5'- and 
3'-sites of the small cytoplasmic 
RNA precursor 
 
 
 
                ǂ            ǂ           ǂ                 ǂ ylqB smc 
 
1,42   chromosome condensation and 
segregation SMC ATPase 
ftsY 1,08  signal recognition particle 
rplJ  1,69 3,42(±0,30) 50S ribosomal protein L10  
                                              ǂ                               ǂ 
                
rplL 1,66  50S ribosomal protein L7/L12  
spoIIE
†
 ND  serine phosphatease  
ǂ                                                                                         
Tig 1,68 1,11(±0,01) trigger factor (prolyl isomerase), 
catalyze in vitro protein folding; 
essential for growth under starvation 
conditions 
 
ǂ      ⃖         ǂ      ⃖              ⃖             ⃖           ⃖          ǂ  
Tsf 1,69 
 
1,31(±0,53) Ts elongation factor  
 
 
                                              ǂ                                          ǂ  
pyrH 1,52 1,74(±0,15) 
 
uridylate kinase 
frr 1,55 1,11(±0,08) ribosome recycling factor 
 
ydjM  2,33  hypothetical protein  
ǂ      ⃖                           ǂ                   ǂ      ⃖          ydjN 1,48  hypothetical protein 
59 
yhdN ND  aldo/keto reductase                 ǂ                   ǂ      ⃖               ⃖                            
ǂ yhdO(plsC) 1,49 1,05(±0,14)  1-acyl-sn-glycerol-3-phosphate 
acyltransferase (lipid metabolism) 
yhfE 1,63 3,65(±0,04) putative endoglucanase  
ǂ       ⃖                             ǂ      ⃖                                              
ǂ 
yhfF 1,40  2,18(±0,09) hypothetical protein 
yjcM 1,48  hypothetical protein  
ǂ      ⃖              ⃖        ǂ      ⃖                          ǂ                 
ylpC(fapR) 1,36  1,16(±0,09) fatty acid biosynthesis transcriptional 
factor 
 
 
 
                                                                                       ǂ 
           ǂ           ǂ                
 
plsX 1,66  putative glycerol-3-phosphate 
acyltransferase PlsX 
fabD 2,42  malonyl CoA-acyl carrier protein 
transacylase 
fabG 2,28  beta-ketoacyl-acyl carrier protein 
reductase 
acpA 2,29  acyl carrier protein 
yokD NR 2,65(±0,25) aminoglycosideN3'-acetyltransferase  
ǂ                                 ǂ                        ⃖           
yqgA 1,80  hypothetical protein      ⃖                           ǂ      ⃖                                            ǂ 
yqxI 1,31   hypothetical protein  
ǂ                                                ǂ      ⃖               ⃖          
yqxJ 1,78  hypothetical protein 
yqxM 0,96  2,65(±0,06) lipoprotein for biofilm formation  
                            ǂǂ      ⃖               ⃖                 ⃖             
                     ⃖          
 
sipW 2,12 1,42(±0,14) type I signal peptidase 
tasA 1,50 2,65(±0,17) major biofilm matrix component 
yuaB  3,33 2,70(±0,25) hypothetical protein                 ǂ                   ǂ                                 ǂ 
yukE 1,46 1,29(±0,06) hypothetical protein  
 
 
ǂ      ⃖               ⃖               ⃖               ⃖                ⃖            
     ⃖                ⃖                 ⃖                           ǂ 
 
yukD 0,85  bacteriocin 
yukC 1,75  membrane-associated enzyme 
involved in bacteriocin production 
yukB 0,46  putative cell division protein 
yukA 1,48  hypothetical protein 
yvaW(sdpA) 1,26  1,08(±0,22) sporulation delay protein-export of 
killing factor 
 
 
                                                                    ǂ 
 
yvaX (sdpB) 2,2 1,68(±0,08) Sporulation delay protein-exporter of 
killing factor SpbC 
yvaY(sdpC) 061  killing factor SdpC 
yvcA* NR 1,56(±0,01)  Lipoprotein      ⃖          ǂ      ⃖               ⃖               ⃖           ǂ      ⃖       
yvcE(cwlO) 2,24 1,70(±0,05) secreted cell wall DL-endopeptidase  
     ⃖              ⃖              ⃖           ǂ      ⃖               ⃖          ǂ 
yveN(epsD) 2,21 2,63(±0,05) extracellular matrix biosynthesis 
enzyme 
 
ǂ                                    ⃖                ⃖                ⃖           
     ⃖               ⃖               ⃖                ⃖               ⃖              ⃖          
     ⃖               ⃖               ⃖                ⃖                ⃖           
     ⃖               ⃖                    
 
yveO(epsE) 2,08 1,34(±0,31) Glycosyltransferase 
yvfA(epsK) 1,49 1,10(±0,21) extracellular matrix component 
exporter 
yvfE(epsN) 0,79 1,02(±0,01) aminotransferase 
yvfF(epsO) 1,79 0,94(±0,05) pyruvyl transferase 
ywcD 1,52 2,04(±0,06) integral inner membrane protein ǂ      ⃖              ⃖               ⃖                 ⃖                            
ywfB(bacA)
†
 
ND  bacilysin biosynthesis protein, 
dehidratase 
 
 
 ywfC(bacB)
 
 ND  isomerase component of bacilysin 
synthetase 
60 
ywfD(bacC)
*
 
 
 NR  bacilysin biosynthesis 
oxidoreductase 
ǂ ywfA ǂ                                                      
                                                   ǂ       ⃖             ǂ  
     ⃖          
ywfE(bacD) ND  alanine-anticapsin ligase 
ywfF(bacE)
* 
NR  efflux protein for bacilysin excretion, 
self-protection against bacilysin 
ywfG* NR  transaminase 
ywfH
†
 ND  carrier protein reductase of bacilysin 
biosynthesis 
yybN 1,76 2,05(±0,24) hypothetical protein  
 
                  ǂ                                                                      
      ⃖               ⃖                           ǂ      ⃖          
yybM 0,87  integral inner membrane protein 
yybL 1,52 1,23(±0,12) integral inner membrane protein 
yybK 1,73  integral inner membrane protein 
yybJ 1,52  ATP-binding cassette protein 
yydF ND  biactive peptide eliciting cell 
envelope stress sensed by the LiaRS 
TCS 
 
 
ǂ      ⃖               ⃖                ⃖                ⃖                ⃖           
            
 
yydG 
 
1,93 
 
1,68(±0,09) 
 
putative AdoMet radical enzyme 
yydH 0,62   membrane-embedded protease 
yydI 0,51   YydIJ: an ATP-binding cassette 
(ABC) transporter 
yydJ 0,73   
 
B. 
Gene 
 
Fold 
difference a 
qPCR b Function Transcriptional Organisation c 
     abh* NR -4,57(±0,28) transcriptional regulator of 
transition state genes (AbrB-like) 
 
ǂ      ⃖               ⃖                            ǂ                                
acoA -1,57 -3,07(±0,22) acetoin dehydrogenase E1 
component (TPP-dependent alpha 
subunit) 
 
 
ǂ                                ǂ                                                    
                ǂ                                 ǂ 
 
acoB -1,54   acetoin dehydrogenase E1 
component (TPP-dependent beta 
subunit) 
acoC -1,56   branched-chain alpha-keto acid 
dehydrogenase subunit E2 
acoL -1,36  dihydrolipoamide dehydrogenase 
aprE -2,35 -3,07(±0,91) extracellular alkaline serine 
protease (subtilisin E) 
ǂ      ⃖                           ǂ      ⃖                                            
ǂ  
argC -1,63 -1,98(±0,22) N-acetyl-gamma-glutamyl-
phosphate reductase 
 
 
 
 
 
                            ǂ                                                    
                                                                    ǂ                
 
argJ -1,89  bifunctional ornithine 
acetyltransferase/N-
acetylglutamate synthase protein 
argB -2,08   acetylglutamate kinase 
argD -2,13  acetylornithine aminotransferase 
carA  -2,22   carbamoyl phosphate synthase 
small subunit 
carB  -2,15  carbamoyl phosphate synthase 
large subunit 
argF  -2,16  ornithine carbamoyltransferase 
argG -1,68   argininosuccinate synthase  
ǂ      ⃖               ⃖            ǂ      ⃖          ǂ      ⃖            ǂ 
     ⃖         ǂ  
argH -2,04   argininosuccinate lyase 
citA -1,50 -2,20(±0,30) citrate synthase 1  
61 
ǂ      ⃖                                      ǂ                ǂ                 ǂ 
citB -1,38 -2,21(±0,21) aconitate hydratase  
ǂ      ⃖               ⃖              ⃖                         ǂ                   
glnR -1,31   -0,73(±0,10) transcriptional regulator (nitrogen 
metabolism) 
 
                    ǂ                                                                    
ǂ  
glnA -1,19  glutamine synthase 
gltA -1,31 -2,04(±0) glutamate synthase (large subunit)  
ǂ      ⃖                           ǂ      ⃖               ⃖                       ǂ 
     ⃖              ⃖          
gltB -1,45  Glutamate synthase [NADPH] 
small chain 
ispA -2,01 -1,68(±0,22) intracellular serine protease  
ǂ     ⃖          ǂ      ⃖                          ǂ      ⃖               ⃖           
msmR -1,48 -1,43(±0,27) transcriptional regulator (LacI 
family) 
     ⃖           ǂ       ⃖                                                  
                                                   ǂ  msmE -1,51  multiple sugar-binding lipoprotein 
pbpE ND -3,44(±1,13) penicillin-binding protein 4* 
(spore cortex) 
 
ǂ       ⃖                 ⃖                           ǂ                  ǂ   racX ND  amino acid racemase 
rapI*
† -1,84(NR) 
 
  response regulator aspartate 
phosphatase 
 
     ⃖                                           ǂ                   ǂ      ⃖           
phrI* NR  phosphatase RapI regulator 
sigW ND -4,31(±0,01) RNA polymerase sigma factor 
sigW 
 
trnSL-Gln2 ǂ                                      ǂ                 
ybbM ND  hypothetical protein 
trpE -1,9 -1,26(±0,05) anthranilate synthase component I  
 
 
 
ǂ      ⃖               ⃖              ⃖             ⃖               ⃖                
     ⃖               ⃖               ⃖                ⃖               ⃖          
  
trpD -2,1   anthranilate 
phosphoribosyltransferase 
trpC -2,62   indole-3-glycerol-phosphate 
synthase 
trpF -2,22   N-(5'-phosphoribosyl) anthranilate 
isomerase 
trpB -2,00   tryptophan synthase subunit beta 
trpA -1,04  tryptophan synthase subunit alpha 
ybfO -1,76 -1,08(±0,06) hypothetical protein; similar to 
erythromycin esterase 
 
                             ǂ                 ǂ                                 ǂ  
ybyB -1,48   hypothetical protein   
ǂ      ⃖                         ǂ      ⃖                            ǂ      ⃖           
yceC -1,00  -0,88(±0,06) putative stress adaptation protein  
 
ǂ                               ǂ      ⃖                                           
                                                                 ǂ                  
 
yceD -1,44   putative stress adaptation protein  
yceE -1,39   putative stress adaptation protein  
yceF -1,73 -1,38(±0,08) putative stress adaptation 
transporter  
yceH -1,43   putative stress adaptation protein  
yneN -1,41  -1,04(±0,19) putative membrane-bound protein 
with a thioredoxin-like domain  
     ⃖                        ǂ                                             ǂ 
yotH -1,80   hypothetical protein   
     ⃖             ⃖                ⃖              ⃖              ⃖              ⃖          
ytsC(bceA) ND -2,68(±0,32) bacitracin ABC efflux transporter 
ATP-binding protein 
 
ǂ      ⃖                        ǂ      ⃖               ⃖               ⃖         
     ⃖         ǂ      ⃖         
ytsD(bceB) ND -3,77(±0,06) Bacitracin export permease protein 
BceB  
yuaF -1,72 -1,12(±0,09) membreane integrity integral inner 
membrane protein 
 
               ǂ      ⃖               ⃖                 ⃖                           ǂ 
     ⃖           ǂ 
 
yuaG -1,46  putative flotillin-like protein  
yuaI -1,62  putative acetyl-transferase 
62 
yvqI (liaI) -1,65 -1(±0,05) putative transmembrane protein  
 
 
     ⃖               ⃖                 ⃖          ǂ      ⃖         ǂ      ⃖           
yvqH(liaH) -1,78  similar to phage-shock protein 
A(PspA) of E. coli 
yvqG(liaG) -1,31   putative membrane-anchored 
hypothetical protein 
yvqF(liaF) -1,05   membrane protein 
yvqE(liaS) -1,02   LiaRS: two component regulatory 
system 
yvqC(liaR) -0,85    
Genes in an operon are grouped together 
a. Numbers indicate the log 2  transformed expression ratio’s. 
b. Numbers indicate the log 2  transformed expression ratio’s. (The mean of 
minimum three independent replicate experiments is given and standart 
deviation of the mean is shown in paranthesis), 
c. transcriptional organization retrieved from 
http://genolist.pasteur.fr/SubtiList/, “ǂ ” indicates the termination sites 
*    Bayes P value higher than acceptable value (>0.01) 
NR no reproducible data obtained 
ND no differential expression observed 
† Expression profiles were elucidated by lacZ-fusion analysis  
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APPENDIX B 
 List of primers used in this study 
acoA EMSA.forward 5’ggc ggt att gga tat gtc aaa 3’ 
acoA EMSA.reverse 5’gta cat cca cag cgc ttt ttc 3’ 
aprE EMSA forward 5’atc cat tgt tct cac gga agc 3’ 
aprE EMSA reverse 5’cgc aaa caa caa gct gat cca 3’ 
argG EMSA forward 5’caa tca tgt cga gag caa ctg 3’ 
argG EMSA reverse 5’acc tcc tga gta tgc taa tac 3’ 
atpI EMSA forward  5’-  gcc ggatcc tca tgt gtc ttg tag cag cgc-3’ 
atpI EMSA reverse 5’- cgg gaattc cat tct tct gac gag cag taa-3’ 
czcD EMSA forward 5’ttg tag ttg aat act acc ctc 3’ 
czcD EMSA reverse 5’tgc tcc ttc att atg att gtg 3’ 
ftsE EMSA forward 5’taa aaa cgg ccg cgg caa tat 3’ 
ftsE EMSA reverse 5’gcc gtt cgg ata ggc ttt ata 3’ 
glnR EMSA forward 5’tacatgcctggatacgaggat 3’ 
glnR EMSA reverse 5’tgg aaa taa agg cat tga gcg 3’ 
gltA EMSA forward 5’gat att tct ccc ttc acg ctc 3’ 
gltA EMSA reverse 5’acg gta gag acc ttg agc ttt 3’ 
hepS EMSA forward 5’gcc gtt gag gac gga gtg aat 3’ 
hepS EMSA reverse 5’gtt cag att ggc taa agt tcc 3’ 
ispA EMSA forward 5’act gtt gca tta tgt agg gcg 3’ 
ispA EMSA reverse 5’cac ata cgg gat caa gcg gat 3’ 
lip EMSA forward 5’aat ggt gtc gtc aca cca aac 3’ 
lip EMSA reverse 5’tac aag tgc aat gat cct tct 3’ 
msmR EMSA forward 5’aat gtc tca aca ctg att ggc 3’ 
msmR EMSA reverse 5’gga aac ttt agc ttt caa ggc 3’ 
pbpE EMSA forward 5’gat tgc aac tgg tct att ttc 3’ 
pbpE EMSA reverse 3’taa cgt ctg aag atg ctt tct 3’ 
ppsA EMSA forward 5’caa tta gaa gaa tga tgc aca 3’ 
ppsA EMSA reverse 5’ttg ggc atg ggt taa aga ata 3’ 
pyrB EMSA forward 5’cag tta tcc ttg tca tcg gtg 3’ 
pyrB EMSA reverse 5’agt gct aag ttc act cat cgt 3’ 
pyrR EMSA forward 5’ctt taa tgg cca acc gct tca 3’ 
pyrR EMSA reverse  5’cag cgc ccg tct aat tgc ctg 3’ 
rapI EMSA forward 5-gca gtc tgg att gtt tgg gta-3’ 
rapI reverse 5’-cgt gac taa gtc gta cgg aat-3’ 
sdpA EcoRI reverse 5’ cgg gaa ttc aat gtt ttc ttc tgt agg gct 3’ 
sdpA forward 5’ agc aat att tca cct cag aa 3’ 
ybfO EMSA forward 5’cga gaa gtg tgc tgg ccg atc 3’ 
ybfO EMSA reverse 5’cag cgg cag ggt cat tct cac 3’ 
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yceC EMSA forward 5’tgc tta aat gaa tca aaa ggc 3’ 
yceC EMSA reverse 5’atc aat tcg ttg acc ttt ttc 3’ 
yhfE EMSA forward 5’ ggg tca tca gaa tat ttc tga 3’ 
yhfE EMSA reverse 5’aat gag ctc cat cgt ttt acg 3’ 
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APPENDIX C 
Luria Bertani (LB) Agar Medium (1000 mL) 
Tryptone                                10 g/L 
Yeast Extract                         5 g/L 
NaCl2                                                        5 g/L 
Agar                                       15 g/L 
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APPENDIX D 
P1 Buffer (pH 8) 
 
Tris-base                                 6.06 gr 
EDTA.2 H2O                          3.72 gr 
Dissolve Tris-base and EDTA with 800 mL dH2O. Adjust pH to 8 with HCl. Adjust 
volume to 1 lt dH2O. Add 100 mg RNase A per liter of P1. 
P2 Buffer 
NaOH                                      8 gr 
SDS solution (20%)                50 mL 
Dissolve NaOH in 950 mL dH2O.  
Add 50 mL SDS solution. 
P3 Buffer  (pH 5.5) 
Potassium acetate                    294.5 gr 
Dissolve in 500 mL dH2O.  
Adjust pH. 
TE Buffer (pH 7) 
Tris base                                  10 mM 
EDTA                                      1 mM 
Adjusted pH 7 with HCl. 
TAE Buffer (50X) 
Tris base (2 moles)                  242 g 
Glacial acetic acid (57.1 mL)  57.1 mL 
EDTA (100mL 0.5M)             100 mL (0.5 M, pH 8.0) 
Add Distilled H2O up to 1L and adjust pH to 8 by HCl. 
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TGE Buffer (10X) 
Tris base (2 moles)                  30,3 g 
Glycine                                    142 g 
EDTA (100mL 0.5M)             37,2 g  
Add distilled H2O up to 1L and adjust pH to 8,4 by HCL  
Low Melting Agarose Gel (1%) 
Agarose                                    0.5 g 
TAE buffer (1X)                      50 mL 
Add 1.5μL EtBr (final concentration: 0.5 μg/mL) before pouring the gel into tray. 
CTAB/NaCl Solution (10 % CTAB/ 0.7 M NaCl) 
4.1 g of NaCl was dissolved in 80 mL of dH2O. Then, 10 g of CTAB (hexadecyl 
trimethyl ammonium bromide) was added and dissolved with vigorously shaking 
and gentle heating up to 65 ° C. Final volume was made up to 100 mL with dH2O. 
Buffers for Purification Under Native Conditions  
Lysis buffer (1 liter)  
NaH2PO4                                  6.90 g  
NaCl                                        17.54 g  
Imidazole (10 mM)                 0.68 g  
Dissolve in 800 ml dH2O and adjust pH to 8.0 using NaOH. Adjust volume to 1 lt 
dH2O.  
Wash buffer (1 liter):  
NaH2PO4                                                 6.90 g  
NaCl                                        17.54 g  
Imidazole (20 mM)                 1.36 g  
Dissolve in 800 ml dH2O and adjust pH to 8.0 using NaOH. Adjust volume to 1 lt 
dH2O.  
Elution buffer (1 liter):  
NaH2PO4                                                  6.90 g  
NaCl                                        17.54 g  
Imidazole (250 mM)               17.00 g  
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Dissolve in 800 ml dH2O and adjust pH to 8.0 using NaOH. Adjust volume to 1 lt 
dH2O.  
SDS-PAGE and Native Gel solutions and buffers  
Monomer solution for SDS-PAGE (12%)  
Acrylamide                               29.5 g  
Bisacrylamide                           0.5 g  
Dissolve in 100 ml of dH2O and stored at 40C in the dark.  
Separating gel buffer for SDS-PAGE  
Tris base (1.5 M)                      18.2 g  
Dissolve in 80 ml dH2O and adjust pH to 8.8. Add distilled H2O up to 100 ml.  
Stacking gel buffer for SDS-PAGE  
Tris-HCl (1 M)                         12.1 g  
Dissolve in 80 ml dH2O and adjust pH to 6.8. Add distilled H2O up to 100 ml.  
3X Loading (Sample) buffer for SDS-PAGE  
Tris base                                    5 ml (0.135 M, pH 6.8)  
Glycerol                                     3 ml  
SDS                                           0.3 g  
DTT                                          231 mg  
Bromophenol blue                    0.03 % (w/v) 
10x Binding Buffer Stock Solution for EMSA  
KCl                                           372 mg  
MgCl2                                      102 mg  
EDTA                                       3.7 mg  
Tris base                                   8 ml (100 mM, pH 8.0)  
Final volume was made up to 10 mL with dH2O.  
5x Binding Buffer  Preperation  
10x Binding Buffer                   0.5ml (Stock solution B)  
Glycerol                                    0.4 ml  
DTT (0.1M)                              0.05 ml  
Add sterile distilled H2O up to 1ml.  
Loading (Sample) buffer for EMSA  
0.25x Native gel buffer             60%  
Glycerol                                    40%  
Bromophenol blue                    0.2% (w/v) 
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APPENDIX E  
Chemical  
 
 
 
 
Supplier  
Acrylamide  Merck  
Agar  
Agarose  
Sigma  
Prona  
Ammonium persulfate  Merck  
Bis-acrylamide  Merck  
Bromophenol blue  Sigma  
Coomassie Brilliant Blue R  Sigma  
CTAB  Sigma  
EDTA  Sigma  
Ethanol  Riedel-de Haën  
Ethidium bromide  Sigma  
DTT  Sigma  
Gilicial Acetic Acid  Riedel-de Haën  
Glycerol  Merck  
Glycine  Merck  
HCl  Merck  
Hepes  AppliChem  
Imidazole  Merck  
IPTG  AppliChem  
KCl  Carlo Erba  
Methanol  Riedel-de Haën  
MgCl2.6H2O  Carlo Erba  
NaCl  Merck  
NaOH  Carlo Erba  
NaH2PO4  Merk  
Phenol-chloroform-isoamylalcohol  Fluka  
SDS  Merck  
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TEMED                                              Carlo Erba  
Tris-base                                              Merck  
X-Gal                                              Sigma  
Yeast Extract                                                                                        Acumedia  
 
Enzymes 
BamHI                                                                                              Fermentas 
NcoI                                                                                                  Fermentas 
EcoRI                                                                                                Fermentas 
Lysozyme                                                                                         AppliChem 
Proteinase K                                                                                      Sigma 
RNAse A                                                                                           Sigma 
Taq DNA Polymerase                                                                       Intron 
T4 DNA Ligase                                                                                 Roche 
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APPENDIX F 
Marker                                                                                               Supplier 
Lambda DNA/EcoRI+ HindIII Marker  (Marker 3)                           Fermentas 
 
 
 
 
 
 
 
 
 
GeneRuler™ DNA Ladder mix, ready-to-use                                   Fermentas  
 
 
 
 
 
 
 
 
Protein molecular mass marker                                                        Fermentas 
 
 
 
 
 
 
 
 
 
 
 
 
74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
75 
 
APPENDIX G 
LABORATORY EQUIPMENT 
Autoclave: Tuttnauer Systec Autoclave (2540 mL) 
Balances: Precisa 620C SCS 
      Precisa 125 A SCS 
Centrifuge: Beckman Coulter, Microfuge 18  
Centrifuge rotor: F241.5P 
Deep freezes and refrigerators: -80°C Heto Ultrafreeze 4410 
           -20°C Arçelik 209lt 
            +4°C Arçelik 
Electrophoresis equipments: E – C mini cell primo EC320 
Gel documentation system: UVI PHotoMW Version 99.05 for Windows 
Incubators: Nüve EN400 
          Nüve EN500 
Orbital shaker incubators: Sertomat S – 2 
              Thermo 430 
Pipettes: Gilson pipetteman 10 μL, 20 μL, 200 μL, 1000 μL 
      Volumate Mettler Toledo 10 μL, 20 μL, 200 μL, 1000 μL 
      Eppendorf research 2,5 μL 10 μL, 20 μL, 200 μL, 1000 μL 
pH meter: Mettler Toledo MP220 
Spectrophotometer: PerkinElmer Lambda25 UV/VIS Spectrometer 
Thermomixer: Eppendorf thermomixer comfort (1.5 mL) 
Transillumunator: Biorad UV transilluminator 2000 
Vortexing machine: Heidolph Raax top  
Waterbaths: Memmert wb-22 
Ultrafiltration tube: VIVASPIN 
Power supply: Bio-Rad 
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